<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="review-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Ther Adv Cardiovasc Dis</journal-id><journal-id journal-id-type="iso-abbrev">Ther Adv Cardiovasc Dis</journal-id><journal-id journal-id-type="pmc-domain-id">3336</journal-id><journal-id journal-id-type="pmc-domain">tacdis</journal-id><journal-id journal-id-type="publisher-id">TAK</journal-id><journal-title-group><journal-title>Therapeutic Advances in Cardiovascular Disease</journal-title></journal-title-group><issn pub-type="ppub">1753-9447</issn><issn pub-type="epub">1753-9455</issn><publisher><publisher-name>SAGE Publications</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11632876</article-id><article-id pub-id-type="pmcid-ver">PMC11632876.1</article-id><article-id pub-id-type="pmcaid">11632876</article-id><article-id pub-id-type="pmcaiid">11632876</article-id><article-id pub-id-type="pmid">39655905</article-id><article-id pub-id-type="doi">10.1177/17539447241305587</article-id><article-id pub-id-type="publisher-id">10.1177_17539447241305587</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Relevance of cardiac imaging in the evolving landscape of infective endocarditis management</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Haouzi</surname><given-names initials="A">Alice</given-names></name><xref rid="fn1-17539447241305587" ref-type="author-notes">*</xref><aff id="aff1-17539447241305587">Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Sydell and Arnold Family Heart, Vascular, and Thoracic Institute, Cleveland Clinic Foundation, Cleveland, OH, USA</aff><role content-type="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role content-type="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role content-type="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role content-type="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role content-type="https://credit.niso.org/contributor-roles/validation/">Validation</role><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#8211; original draft</role></contrib><contrib contrib-type="author"><name name-style="western"><surname>Khayata</surname><given-names initials="M">Mohamed</given-names></name><xref rid="fn1-17539447241305587" ref-type="author-notes">*</xref><aff id="aff2-17539447241305587">Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Sydell and Arnold Family Heart, Vascular, and Thoracic Institute, Cleveland Clinic Foundation, Cleveland, OH, USA</aff><role content-type="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role content-type="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role content-type="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#8211; original draft</role></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-2985-7468</contrib-id><name name-style="western"><surname>Xu</surname><given-names initials="B">Bo</given-names></name><xref rid="corresp1-17539447241305587" ref-type="corresp"/><aff id="aff3-17539447241305587">Section of Cardiovascular Imaging, Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Sydell and Arnold Family Heart, Vascular, and Thoracic Institute, Cleveland Clinic Foundation, 9500 Euclid Avenue, Desk J1-5, Cleveland, OH 44195, USA</aff><role content-type="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role content-type="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role content-type="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role content-type="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role content-type="https://credit.niso.org/contributor-roles/resources/">Resources</role><role content-type="https://credit.niso.org/contributor-roles/supervision/">Supervision</role><role content-type="https://credit.niso.org/contributor-roles/visualization/">Visualization</role><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review &amp; editing</role></contrib></contrib-group><author-notes><corresp id="corresp1-17539447241305587"><email>xub@ccf.org</email></corresp><fn fn-type="other" id="fn1-17539447241305587"><label>*</label><p>These authors are joint first authors</p></fn></author-notes><pub-date pub-type="epub"><day>10</day><month>12</month><year>2024</year></pub-date><pub-date pub-type="collection"><year>2024</year></pub-date><volume>18</volume><issue-id pub-id-type="pmc-issue-id">452761</issue-id><elocation-id>17539447241305587</elocation-id><history><date date-type="received"><day>13</day><month>6</month><year>2024</year></date><date date-type="accepted"><day>19</day><month>11</month><year>2024</year></date></history><pub-history><event event-type="pmc-release"><date><day>10</day><month>12</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>11</day><month>12</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-12-17 14:25:13.860"><day>17</day><month>12</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s), 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder content-type="sage">SAGE Publications Ltd unless otherwise noted. Manuscript content on this site is licensed under Creative Commons Licenses</copyright-holder><license><ali:license_ref specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">https://creativecommons.org/licenses/by-nc/4.0/</ext-link>) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://us.sagepub.com/en-us/nam/open-access-at-sage">https://us.sagepub.com/en-us/nam/open-access-at-sage</ext-link>).</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="10.1177_17539447241305587.pdf"/><abstract><p>Infective endocarditis (IE) is an increasingly recognized condition with high morbidity. Patients with atypical symptoms, culture-negative infections, and prosthetic cardiac devices and implants represent challenging populations to evaluate and manage. Recent major society guidelines have recommended the appropriate incorporation of multimodality imaging in the evaluation of these more complex IE cases. This article draws on the available literature regarding the different cardiac imaging modalities and discusses the role of multimodality imaging in IE.</p></abstract><kwd-group><kwd>cardiac computed tomography</kwd><kwd>echocardiography</kwd><kwd>infective endocarditis</kwd><kwd>multimodality cardiovascular imaging</kwd><kwd>nuclear imaging</kwd><kwd>positron emission tomography</kwd><kwd>transesophageal echocardiography</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>January-December 2024</meta-value></custom-meta><custom-meta><meta-name>typesetter</meta-name><meta-value>ts1</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="section1-17539447241305587"><title>Introduction</title><p>Infective endocarditis (IE) is a serious condition associated with significant morbidity and high 1-year mortality rates, estimated to be around 30%, despite evolving diagnostic and therapeutic strategies.<sup><xref rid="bibr1-17539447241305587" ref-type="bibr">1</xref>,<xref rid="bibr2-17539447241305587" ref-type="bibr">2</xref></sup> The incidence of IE has also been rising since the 21st century. Over the past two decades, there has been a reported increase in the incidence of IE in North America and a twofold increase across Europe.<sup><xref rid="bibr3-17539447241305587" ref-type="bibr">3</xref>
<xref rid="bibr4-17539447241305587" ref-type="bibr"/>&#8211;<xref rid="bibr5-17539447241305587" ref-type="bibr">5</xref></sup> This is partly owing to a growing, at-risk, and aging population and an increase in prosthetic valve and cardiac device implantation.<sup>
<xref rid="bibr6-17539447241305587" ref-type="bibr">6</xref>
</sup> The improved detection of IE is also potentially playing a role in this rising incidence due to an increase in the use of echocardiography across hospital centers and the introduction of more advanced imaging techniques such as dedicated cardiac computed tomography (CCT), nuclear imaging, and cardiac magnetic resonance imaging (MRI).<sup>
<xref rid="bibr4-17539447241305587" ref-type="bibr">4</xref>
</sup> The utility of multimodality imaging has in fact been highlighted in the recently updated American College of Cardiology (ACC)/American Heart Association (AHA) and European Society of Cardiology (ESC) guidelines<sup><xref rid="bibr6-17539447241305587" ref-type="bibr">6</xref>,<xref rid="bibr7-17539447241305587" ref-type="bibr">7</xref></sup> and continues to garner greater recognition in clinical practice. In this review, we focus on the strengths and limitations of these imaging modalities as they pertain to the evaluation of IE in both native and prosthetic valves. We also present a focused section on cardiac implantable device related IE and infection of surgical grafts with relevant illustrative cases. All the cases presented in this review are original and unique.</p></sec><sec id="section2-17539447241305587"><title>Epidemiology</title><p>In a nationwide study using the National Inpatient Sample, it was determined that hospitalizations for IE reached approximately 600,000 between 2003 and 2016 in the United States.<sup>
<xref rid="bibr8-17539447241305587" ref-type="bibr">8</xref>
</sup> The same study noted that the incidence of IE hospitalizations had increased significantly over the years from 34,488 in 2003 to 54,405 in 2016.<sup>
<xref rid="bibr8-17539447241305587" ref-type="bibr">8</xref>
</sup> A similar trend was observed in a systemic review by Talha et&#8239;al. of IE cases in Europe, noting an increase in yearly incidence of IE of 0.27 cases per 100,000 people, effectively resulting in a doubling of IE hospitalizations in Europe over the past two decades.<sup>
<xref rid="bibr4-17539447241305587" ref-type="bibr">4</xref>
</sup> Mortality associated with IE remains high, with an estimated in-hospital mortality of 14%&#8211;22% and 1-year mortality up to 40%.<sup><xref rid="bibr9-17539447241305587" ref-type="bibr">9</xref>
<xref rid="bibr10-17539447241305587" ref-type="bibr"/><xref rid="bibr11-17539447241305587" ref-type="bibr"/><xref rid="bibr12-17539447241305587" ref-type="bibr"/>&#8211;<xref rid="bibr13-17539447241305587" ref-type="bibr">13</xref></sup> A large analysis using the Centers for Disease Control and Prevention&#8217;s Wide-Ranging Online Data for Epidemiologic Research database from 1999 to 2020 found that while mortality rates have seen a significant decline for those over the age of 55, there was a notable acceleration in IE-associated morality in the younger 25- to 45-year age group. This increase coincided with specific regions of the United States including Kentucky, Tennessee, and West Virginia, which have seen a notable rise in intravenous drug use and the opioid epidemic.<sup><xref rid="bibr5-17539447241305587" ref-type="bibr">5</xref>,<xref rid="bibr10-17539447241305587" ref-type="bibr">10</xref></sup></p><p>The incidence of native valve infective endocarditis (NVIE) is approximately 2&#8211;10 cases per 100,000&#8201;person-years.<sup><xref rid="bibr1-17539447241305587" ref-type="bibr">1</xref>,<xref rid="bibr14-17539447241305587" ref-type="bibr">14</xref></sup> Prosthetic valve procedures including transcatheter aortic valve replacement (TAVR) have significantly increased over the last decade,<sup><xref rid="bibr15-17539447241305587" ref-type="bibr">15</xref>,<xref rid="bibr16-17539447241305587" ref-type="bibr">16</xref></sup> which has led to an increase in the incidence of prosthetic valve infective endocarditis (PVIE), now accounting for approximately 20%&#8211;30% of all IE cases.<sup>
<xref rid="bibr15-17539447241305587" ref-type="bibr">15</xref>
</sup> The incidence of PVIE is approximately 1%&#8211;4% in the first year following surgery with an estimated incidence of 1% per year thereafter.<sup>
<xref rid="bibr17-17539447241305587" ref-type="bibr">17</xref>
</sup> The crude rate of IE is 0.43 per 100 patients for mechanical valves and 0.60 per 100 patients for bioprosthetic valves within 1&#8211;5&#8201;years following aortic valve replacement.<sup>
<xref rid="bibr18-17539447241305587" ref-type="bibr">18</xref>
</sup></p><p>While cardiovascular implantable electronic devices (CIEDs) such as pacemakers and defibrillators are widely used, the exact epidemiology and natural history of CIED-related infective endocarditis (CIED-IE) is still not well-defined, and evidence is mainly driven by sporadic case reports and case series.<sup><xref rid="bibr1-17539447241305587" ref-type="bibr">1</xref>,<xref rid="bibr2-17539447241305587" ref-type="bibr">2</xref></sup> A study from the EURO-ENDO registry demonstrated that diagnosis of CIED-IE was dependent on imaging findings in at least 85% of cases and that almost 20% could not reach definite diagnostic criteria, with underutilization of multimodality imaging in these cases.<sup>
<xref rid="bibr19-17539447241305587" ref-type="bibr">19</xref>
</sup> Prognosis for CIED-IE also remains poor,<sup>
<xref rid="bibr19-17539447241305587" ref-type="bibr">19</xref>
</sup> similar to other cardiac prosthetic infections including aortic graft and ventricular assist device infections.<sup><xref rid="bibr20-17539447241305587" ref-type="bibr">20</xref>
<xref rid="bibr21-17539447241305587" ref-type="bibr"/>&#8211;<xref rid="bibr22-17539447241305587" ref-type="bibr">22</xref></sup></p></sec><sec id="section3-17539447241305587"><title>Clinical manifestations</title><p>IE has a wide spectrum of clinical manifestations.<sup><xref rid="bibr23-17539447241305587" ref-type="bibr">23</xref>,<xref rid="bibr24-17539447241305587" ref-type="bibr">24</xref></sup> Fever is the most common presenting symptom reported in approximately 70%&#8211;80% of cases.<sup><xref rid="bibr23-17539447241305587" ref-type="bibr">23</xref><xref rid="bibr24-17539447241305587" ref-type="bibr"/>&#8211;<xref rid="bibr25-17539447241305587" ref-type="bibr">25</xref></sup> A new murmur and worsening of a known murmur are also common and were reported in 48%&#8211;70% of cases.<sup><xref rid="bibr23-17539447241305587" ref-type="bibr">23</xref>,<xref rid="bibr24-17539447241305587" ref-type="bibr">24</xref></sup> &#8220;Classic&#8221; examination manifestations such as splinter hemorrhages, Janeway lesions, and Roth&#8217;s spots are much less frequent in routine clinical practice, in the order of 0.5%&#8211;5%.<sup><xref rid="bibr6-17539447241305587" ref-type="bibr">6</xref>,<xref rid="bibr24-17539447241305587" ref-type="bibr">24</xref></sup> Systemic complications including sepsis, meningitis, heart failure, pulmonary emboli, stroke, acute peripheral arterial occlusion, and renal failure are all well described in IE.<sup><xref rid="bibr23-17539447241305587" ref-type="bibr">23</xref>,<xref rid="bibr24-17539447241305587" ref-type="bibr">24</xref></sup></p></sec><sec id="section4-17539447241305587"><title>Diagnosis</title><p>The diagnosis of IE has classically relied on the modified Duke criteria, first established in the year 2000. These criteria are based on microbiology findings, clinical features with an emphasis on evidence of embolic events by physical examination, and imaging findings via echocardiography.<sup><xref rid="bibr6-17539447241305587" ref-type="bibr">6</xref>,<xref rid="bibr26-17539447241305587" ref-type="bibr">26</xref>,<xref rid="bibr27-17539447241305587" ref-type="bibr">27</xref></sup> Despite the widespread use of the modified Duke criteria, major limitations have surfaced, particularly in the presence of culture-negative organisms<sup><xref rid="bibr28-17539447241305587" ref-type="bibr">28</xref>,<xref rid="bibr29-17539447241305587" ref-type="bibr">29</xref></sup> and cardiac prosthetic material that renders evaluation by echocardiography more challenging, with up to 30% of IE cases reported to be normal or inconclusive by transthoracic echocardiography (TTE) and transesophageal echocardiography (TEE).<sup><xref rid="bibr6-17539447241305587" ref-type="bibr">6</xref>,<xref rid="bibr30-17539447241305587" ref-type="bibr">30</xref></sup> For this reason, recent ESC guidelines in 2023 considered findings suggestive of IE in other imaging modalities (CCT, 18F-fluorodeoxyglucose positron emission tomography/computed tomography (<sup>18</sup>FDG-PET)/CT, white blood cell single-photon emission CT/CT (WBC-SPECT/CT), and cerebral MRI) as major and minor criteria for the diagnosis of IE and its extracardiac manifestations, resulting in superior diagnostic performance compared to the traditional Duke criteria.<sup>
<xref rid="bibr6-17539447241305587" ref-type="bibr">6</xref>
</sup> The 2023 Duke International Society of Cardiovascular Disease (ISCVD) criteria have proposed updates to the diagnostic criteria of IE. These updates included more imaging modalities (CCT and (<sup>18</sup>FDG-PET)/CT) as a new major clinical criterion.<sup>
<xref rid="bibr30-17539447241305587" ref-type="bibr">30</xref>
</sup></p><p>2023 Duke-ISCVD criteria could be superior in detecting IE. Goehringer et&#8239;al. performed a retrospective analysis to evaluate the sensitivity and specificity of the 2023 Duke-ISCVD criteria in detecting IE compared to the traditional modified Duke criteria and the 2015 ESC criteria. 2023 Duke-ISCVD criteria had higher sensitivity (97.6% vs 93.2% and 95%, <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001), respectively, but had lower specificity on the other hand (46% vs 61.3% and 60.5%), respectively.<sup>
<xref rid="bibr31-17539447241305587" ref-type="bibr">31</xref>
</sup>
<xref rid="table1-17539447241305587" ref-type="table">Table 1</xref> summarizes the benefits and limitations of these different imaging modalities, with a review of the current literature below.</p><table-wrap position="float" id="table1-17539447241305587" orientation="portrait"><label>Table 1.</label><caption><p>Comparison between different cardiac imaging modalities in their applications for infective endocarditis evaluation.</p></caption><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="10.1177_17539447241305587-table1.jpg"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Cardiac imaging modality</th><th align="left" rowspan="1" colspan="1">Advantages</th><th align="left" rowspan="1" colspan="1">Disadvantages</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">TTE</td><td rowspan="1" colspan="1">Easily available, low cost, high temporal resolution, no radiation exposure, provides hemodynamic evaluation</td><td rowspan="1" colspan="1">Limited evaluation of PVIE and perivalvular complications, operator dependent</td></tr><tr><td rowspan="1" colspan="1">TEE</td><td rowspan="1" colspan="1">Easily available, high temporal resolution, no radiation exposure, good visualization of perivalvular complications</td><td rowspan="1" colspan="1">Minimally invasive, cannot differentiate infection from sterile mass, limited evaluation of graft and extracardiac infection</td></tr><tr><td rowspan="1" colspan="1">CCT</td><td rowspan="1" colspan="1">Good spatial resolution, excellent evaluation of perivalvular complications, concomitant preoperative planning</td><td rowspan="1" colspan="1">Radiation exposure, possible nephrotoxicity from contrast agent, limited image quality with suboptimal breath-hold and tachycardia</td></tr><tr><td rowspan="1" colspan="1">MRI</td><td rowspan="1" colspan="1">Cardiac MRI provides information on cardiac anatomy, valvular function, hemodynamic assessment, and mass characterization, brain MRI used for subclinical embolization events detection</td><td rowspan="1" colspan="1">Affected by magnetic artifacts from prosthetic valves or CIEDs, limited spatial resolution, data lacking in larger patient cohorts</td></tr><tr><td rowspan="1" colspan="1"><sup>
<xref rid="bibr18-17539447241305587" ref-type="bibr">18</xref>
</sup>F-FDG-PET/CT</td><td rowspan="1" colspan="1">Allows evaluation of CIED-IE and extracardiac foci of infection, an excellent diagnostic tool for PVIE when combined with other imaging modalities</td><td rowspan="1" colspan="1">Poor sensitivity in NVIE, false positives in the early postoperative period or the presence of other inflammatory processes, local expertise required for scanning protocols, radiation exposure</td></tr><tr><td rowspan="1" colspan="1">WBC-SPECT/CT</td><td rowspan="1" colspan="1">Wider availability compared to <sup>18</sup>F-FDG-PET/CT, highly reliable in the early postoperative period</td><td rowspan="1" colspan="1">Less accurate in prolonged antibiotic use and infections from non-pyogenic microorganisms (fungal, enterococcus, Coxiella, etc.), radiation exposure</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="table-fn1-17539447241305587"><p>CCT, cardiac computed tomography; CIED-IE, cardiovascular implantable electronic device-related infective endocarditis; <sup>18</sup>F-FDG-PET/CT, 18 fluorodeoxyglucose positron emission tomography/computed tomography; MRI, magnetic resonance imaging, NVIE, native valve infective endocarditis; PVIE, prosthetic valve infective endocarditis; TEE, transesophageal echocardiogram; TTE, transthoracic echocardiogram; WBC-SPECT/CT, white blood cell single-photon emission computed tomography/computed tomography.</p></fn></table-wrap-foot></table-wrap></sec><sec id="section5-17539447241305587"><title>Echocardiographic imaging in IE</title><sec id="section6-17539447241305587"><title>Technical aspects, indications, and main findings</title><p>TTE is a widely available, affordable, noninvasive tool that can be performed rapidly and with no radiation exposure.<sup><xref rid="bibr31-17539447241305587" ref-type="bibr">31</xref>,<xref rid="bibr32-17539447241305587" ref-type="bibr">32</xref></sup> Due to these features, TTE remains the cornerstone modality in the evaluation of endocarditis. Echocardiography is the first-line imaging modality for suspected IE per both the 2020 AHA/ACC and 2023 ESC guidelines.<sup><xref rid="bibr3-17539447241305587" ref-type="bibr">3</xref>,<xref rid="bibr4-17539447241305587" ref-type="bibr">4</xref></sup> TTE should be also considered in all cases for further evaluation and prognostication, particularly, in patients with prosthetic valves or implanted devices.<sup><xref rid="bibr3-17539447241305587" ref-type="bibr">3</xref>,<xref rid="bibr4-17539447241305587" ref-type="bibr">4</xref></sup></p><p>In addition to vegetation visualization, echocardiography can be used to identify infectious complications such as perivalvular extension of the infection, abscess or fistula formation, or prosthesis malfunction and dehiscence. It also plays an important role in quantification of valvular regurgitation and stenosis.<sup>
<xref rid="bibr33-17539447241305587" ref-type="bibr">33</xref>
</sup> Echocardiography also serves a key role in the clinical evaluation of the patient and can provide important hemodynamic information, including stroke volume, biventricular function, filling pressures, and more. TEE can provide peri-operative assessment and assist in determining the optimal surgical approach and the feasibility of valve repair.<sup>
<xref rid="bibr33-17539447241305587" ref-type="bibr">33</xref>
</sup></p></sec><sec id="section7-17539447241305587"><title>Sensitivity, specificity, and limitations</title><p>In a large meta-analysis of 16 studies, the sensitivity and specificity of TTE for IE detection of all types of IE were reported to be 61% and 94%, respectively.<sup>
<xref rid="bibr34-17539447241305587" ref-type="bibr">34</xref>
</sup> Despite its many advantages, echocardiography, and TTE specifically, does have several important limitations. It is highly operator dependent and image quality can be significantly affected by patient factors that result in suboptimal imaging windows. Vegetations usually &lt;5&#8201;mm can be missed on TTE such that early cases of IE may require repeat imaging 5&#8211;7&#8201;days after initial TTE or further evaluation with TEE.<sup>
<xref rid="bibr6-17539447241305587" ref-type="bibr">6</xref>
</sup> The evaluation of PVIE presents a particular challenge in TTE, for which the sensitivity is as low as 30% compared to approximately 70% in NVIE.<sup><xref rid="bibr35-17539447241305587" ref-type="bibr">35</xref>,<xref rid="bibr36-17539447241305587" ref-type="bibr">36</xref>,<xref rid="bibr37-17539447241305587" ref-type="bibr">37</xref></sup>
<xref rid="fig1-17539447241305587" ref-type="fig">Figure 1</xref> clearly highlights the challenge of imaging prosthetic material by TTE, even in the presence of a large vegetation. This is in part due to acoustic shadowing from the prosthesis thereby limiting visualization but also the manifestation of PVIE itself, which frequently involves the paravalvular space or part of the prosthesis without overt formation of vegetations, but rather thickening or irregularity around the prosthetic ring. TEE can be used in these scenarios and yields a very high sensitivity for diagnosing PVIE in a range of 86%&#8211;94% and specificity of 88%, as noted in a large series of patients with PVIE by Daniel et&#8239;al.<sup>
<xref rid="bibr38-17539447241305587" ref-type="bibr">38</xref>
</sup> Cardiac complications like abscess formation can likewise be difficult to detect on TTE but has reasonable detection in TEE; in a French study of 233 patients with IE by Choussat et&#8239;al., sensitivity for abscess detection with TTE and TEE were found to be 36% and 80%, respectively.<sup>
<xref rid="bibr39-17539447241305587" ref-type="bibr">39</xref>
</sup> 3D TEE has also emerged as a helpful complementary tool. Notably 3D assessment tends to yield larger measurements of vegetation given its ability for volumetric reconstruction, which can have important implications for determining embolization risk and surgical timing.<sup>
<xref rid="bibr40-17539447241305587" ref-type="bibr">40</xref>
</sup> A retrospective study by Montan&#233; et&#8239;al. noted a significant sensitivity increase in IE detection with TEE from 85.7% in 2011 to 95.3% in 2019, thought to be partly due to the improved frame rate and resolution of modern TEE probes, as well as a significant increase of almost 27% in the use of 3D technology during that time.<sup>
<xref rid="bibr41-17539447241305587" ref-type="bibr">41</xref>
</sup> In summary, TEE should be considered in most cases of IE when appropriate since it improves the diagnostic performance and detection of the lesions and associated complications.</p><fig position="float" id="fig1-17539447241305587" orientation="portrait"><label>Figure 1.</label><caption><p>Thirty-eight-year-old woman with a history of intravenous drug use and prior endocarditis requiring tricuspid valve replacement presents with 2&#8201;weeks of fevers and shortness of breath. Parasternal short-axis and four-chamber views on TTE (a, c) and TEE (b, d). A bioprosthetic tricuspid valve is seen by TTE but no vegetation can be clearly appreciated. In comparison, large mobile vegetation on the prosthetic tricuspid valve is clearly appreciated by TEE (arrow), with 3D reconstruction (e) yielding a vegetation size of 2.3&#8201;cm.</p><p>TEE, transesophageal echocardiography; TTE, transthoracic echocardiography.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="10.1177_17539447241305587-fig1.jpg"/></fig><p>Even with the availability of modern TTE and TEE technology, certain populations remain difficult to image with echocardiography. Patients with TAVR-related PVIE, for instance, can present with atypical imaging findings that make applying the modified Duke Criteria for diagnosis more challenging.<sup><xref rid="bibr41-17539447241305587" ref-type="bibr">41</xref>,<xref rid="bibr42-17539447241305587" ref-type="bibr">42</xref></sup> Valve dehiscence typically does not occur in this population as the valve is maintained in place via radial force rather than by sutures, and valve regurgitation from PVIE can be mistaken for postoperative paravalvular leak.<sup>
<xref rid="bibr43-17539447241305587" ref-type="bibr">43</xref>
</sup> In a 55-patient study with TAVR PVIE, among whom 85% underwent TEE, vegetation was only noted in a quarter of patients, and almost a third had no overt imaging findings at all. Signs of TAVR PVIE are often more subtle and, if present, may show only leaflet thickening or increased valvular gradients.<sup>
<xref rid="bibr44-17539447241305587" ref-type="bibr">44</xref>
</sup> Similarly, CIED-related IE represents a challenging population to evaluate; again, sensitivity with TEE is significantly higher than with TTE (90% vs 22%&#8211;43%),<sup>
<xref rid="bibr45-17539447241305587" ref-type="bibr">45</xref>
</sup> but vegetations can be missed if they lie in extracardiac segments of the lead that cannot be visualized, and TEE cannot delineate infected vegetation from sterile mass or thrombus.<sup><xref rid="bibr46-17539447241305587" ref-type="bibr">46</xref>,<xref rid="bibr47-17539447241305587" ref-type="bibr">47</xref></sup> In addition, challenging clinical conditions including IE affecting mitral annular calcification can be difficult to diagnose using echocardiography alone<sup><xref rid="bibr48-17539447241305587" ref-type="bibr">48</xref>,<xref rid="bibr49-17539447241305587" ref-type="bibr">49</xref></sup> (<xref rid="table2-17539447241305587" ref-type="table">Table 2</xref>).</p><table-wrap position="float" id="table2-17539447241305587" orientation="portrait"><label>Table 2.</label><caption><p>Sensitivities and specificities of different imaging modalities in diagnosing different types of infective endocarditis.</p></caption><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="10.1177_17539447241305587-table2.jpg"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Imaging modality</th><th align="left" rowspan="1" colspan="1">Sensitivity</th><th align="left" rowspan="1" colspan="1">Specificity</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Transthoracic echocardiography</td><td rowspan="1" colspan="1">61% (both NVIE and PVIE)<sup>
<xref rid="bibr32-17539447241305587" ref-type="bibr">32</xref>
</sup>
<break/>70% (NVIE)<sup><xref rid="bibr33-17539447241305587" ref-type="bibr">33</xref>,<xref rid="bibr34-17539447241305587" ref-type="bibr">34</xref></sup>
<break/>30% (PVIE)<sup><xref rid="bibr33-17539447241305587" ref-type="bibr">33</xref>,<xref rid="bibr34-17539447241305587" ref-type="bibr">34</xref></sup>
<break/>36% (abscess)<sup>
<xref rid="bibr36-17539447241305587" ref-type="bibr">36</xref>
</sup>
<break/>22%&#8211;43% (CIED-IE)<sup>
<xref rid="bibr43-17539447241305587" ref-type="bibr">43</xref>
</sup></td><td rowspan="1" colspan="1">94% (both NVIE and PVIE)<sup>
<xref rid="bibr32-17539447241305587" ref-type="bibr">32</xref>
</sup></td></tr><tr><td rowspan="1" colspan="1">Transesophageal echocardiography</td><td rowspan="1" colspan="1">86%&#8211;95% (PVIE)<sup>
<xref rid="bibr35-17539447241305587" ref-type="bibr">35</xref>
</sup>
<break/>33%&#8211;80% (abscess)<sup><xref rid="bibr35-17539447241305587" ref-type="bibr">35</xref>,<xref rid="bibr52-17539447241305587" ref-type="bibr">52</xref></sup>
<break/>95.3% (3D) (both NVIE and PVIE)<sup>
<xref rid="bibr38-17539447241305587" ref-type="bibr">38</xref>
</sup>
<break/>90% (CIED-IE)<sup>
<xref rid="bibr43-17539447241305587" ref-type="bibr">43</xref>
</sup>
<break/>64%&#8211;67% (pseudoaneurysm)<sup><xref rid="bibr51-17539447241305587" ref-type="bibr">51</xref>,<xref rid="bibr52-17539447241305587" ref-type="bibr">52</xref></sup></td><td rowspan="1" colspan="1">88% (PVIE)<sup>
<xref rid="bibr35-17539447241305587" ref-type="bibr">35</xref>
</sup></td></tr><tr><td rowspan="1" colspan="1">Cardiac computed tomography</td><td rowspan="1" colspan="1">70%&#8211;80% (both NVIE and PVIE)<sup><xref rid="bibr48-17539447241305587" ref-type="bibr">48</xref>,<xref rid="bibr49-17539447241305587" ref-type="bibr">49</xref></sup>
<break/>52.2% (vegetations &lt;10&#8201;mm)<sup>
<xref rid="bibr48-17539447241305587" ref-type="bibr">48</xref>
</sup>
<break/>81%&#8211;100% (pseudoaneurysm)<sup><xref rid="bibr51-17539447241305587" ref-type="bibr">51</xref>,<xref rid="bibr52-17539447241305587" ref-type="bibr">52</xref></sup>
<break/>75% (abscess)<sup>
<xref rid="bibr52-17539447241305587" ref-type="bibr">52</xref>
</sup></td><td rowspan="1" colspan="1">94% (PVIE)<sup>
<xref rid="bibr50-17539447241305587" ref-type="bibr">50</xref>
</sup></td></tr><tr><td rowspan="1" colspan="1"><sup>
<xref rid="bibr18-17539447241305587" ref-type="bibr">18</xref>
</sup>F-FDG PET/CT</td><td rowspan="1" colspan="1">73%&#8211;93% (PVIE)<sup><xref rid="bibr57-17539447241305587" ref-type="bibr">57</xref>,<xref rid="bibr59-17539447241305587" ref-type="bibr">59</xref>,<xref rid="bibr60-17539447241305587" ref-type="bibr">60</xref></sup>
<break/>22%&#8211;36.9% (NVIE)<sup><xref rid="bibr56-17539447241305587" ref-type="bibr">56</xref>,<xref rid="bibr57-17539447241305587" ref-type="bibr">57</xref></sup>
<break/>80% (NVIE with scan preparation and optimized glucose suppression)<sup>
<xref rid="bibr58-17539447241305587" ref-type="bibr">58</xref>
</sup>
<break/>16.3%&#8211;76.2% (CIED-IE)<sup><xref rid="bibr17-17539447241305587" ref-type="bibr">17</xref>,<xref rid="bibr59-17539447241305587" ref-type="bibr">59</xref></sup>
<break/>59% (PVIE with machine learning)<sup>
<xref rid="bibr67-17539447241305587" ref-type="bibr">67</xref>
</sup></td><td rowspan="1" colspan="1">99.1% (NVIE)<sup>
<xref rid="bibr56-17539447241305587" ref-type="bibr">56</xref>
</sup>
<break/>84% (PVIE)<sup>
<xref rid="bibr59-17539447241305587" ref-type="bibr">59</xref>
</sup>
<break/>83% (PVIE with machine learning)<sup>
<xref rid="bibr67-17539447241305587" ref-type="bibr">67</xref>
</sup></td></tr><tr><td rowspan="1" colspan="1">WBC-SPECT/CT</td><td rowspan="1" colspan="1">90% (both NVIE and PVIE)<sup>
<xref rid="bibr72-17539447241305587" ref-type="bibr">72</xref>
</sup>
<break/>64%&#8211;87% (post-cardiac surgery)<sup><xref rid="bibr73-17539447241305587" ref-type="bibr">73</xref>,<xref rid="bibr68-17539447241305587" ref-type="bibr">68</xref></sup>
<break/>94% (CIED-IE)<sup>
<xref rid="bibr75-17539447241305587" ref-type="bibr">75</xref>
</sup>
<break/>71.4% (LVAD)<sup>
<xref rid="bibr77-17539447241305587" ref-type="bibr">77</xref>
</sup></td><td rowspan="1" colspan="1">100% (both NVID and PVID)<sup>
<xref rid="bibr72-17539447241305587" ref-type="bibr">72</xref>
</sup>
<break/>100% (post-cardiac surgery)<sup><xref rid="bibr68-17539447241305587" ref-type="bibr">68</xref>,<xref rid="bibr73-17539447241305587" ref-type="bibr">73</xref></sup>
<break/>100% (CIED-IE)<sup>
<xref rid="bibr75-17539447241305587" ref-type="bibr">75</xref>
</sup>
<break/>100% (LVAD)<sup><xref rid="bibr76-17539447241305587" ref-type="bibr">76</xref>,<xref rid="bibr77-17539447241305587" ref-type="bibr">77</xref></sup></td></tr></tbody></table></alternatives><table-wrap-foot><fn id="table-fn2-17539447241305587"><p>CIED-IE, cardiac implanted electronic devices infective endocarditis; <sup>18</sup>F-FDG PET/CT, <sup>18</sup>F-Fluorodeoxyglucose positron emission tomography/computed tomography; LVAD, left ventricular assisted device; NVIE, native valve infective endocarditis; PVIE, prosthetic valve infective endocarditis; WBC-SPECT/CT, white blood cell single-photon emission computed tomography/computed tomography.</p></fn></table-wrap-foot></table-wrap></sec></sec><sec id="section8-17539447241305587"><title>Summary</title><p>TTE is the first-line modality in suspected IE, and TEE should be considered in most cases. Considering TEE is particularly important in patients with PVIE, suspected abscess, and CIED-IE. 3D images should be acquired when performing the TEE due to its advantage in allowing multiplanar reconstruction leading to higher diagnostic sensitivity.</p></sec><sec id="section9-17539447241305587"><title>CCT in IE</title><sec id="section10-17539447241305587"><title>Technical aspects</title><p>Cardiac CT has gained increasing attention over recent years in the work-up of IE due to its ability to provide both a detailed anatomical evaluation of the infection and important preoperative planning information, including defining coronary anatomy and the relationship between cardiac structures and the sternum. Specialized protocols are required for optimal diagnostic yield, including the use of multiphase electrocardiogram (ECG)-synchronized imaging, thin sections (ideally 0.75&#8201;mm or less), and appropriately timed contrast agents to highlight the anticipated infected sites.<sup><xref rid="bibr47-17539447241305587" ref-type="bibr">47</xref>,<xref rid="bibr50-17539447241305587" ref-type="bibr">50</xref></sup></p></sec><sec id="section11-17539447241305587"><title>Indications according to different guidelines</title><p>Incremental developments in CCT have made it an important complementary tool to echocardiography, and this has been reflected in updated IE guidelines including the 2023 ESC and 2020 ACC/AHA guidelines.<sup><xref rid="bibr6-17539447241305587" ref-type="bibr">6</xref>,<xref rid="bibr7-17539447241305587" ref-type="bibr">7</xref></sup> The former has in fact incorporated the presence of embolic events by imaging as a minor criterion,<sup>
<xref rid="bibr6-17539447241305587" ref-type="bibr">6</xref>
</sup> while the latter has made a class 2A recommendation for the use of CCT as adjunctive imaging in IE.<sup>
<xref rid="bibr7-17539447241305587" ref-type="bibr">7</xref>
</sup> The 2023 ESC and the 2023 Duke-ISCVID diagnostic criteria, on the other hand, consider as a major imaging criterion any findings typical of IE (i.e., vegetation, perforation, abscess, pseudoaneurysm).<sup><xref rid="bibr5-17539447241305587" ref-type="bibr">5</xref>,<xref rid="bibr30-17539447241305587" ref-type="bibr">30</xref></sup></p></sec><sec id="section12-17539447241305587"><title>Sensitivity, specificity, and limitations</title><p>Given the rising importance of CCT in the evaluation of IE, a number of studies have sought to define the sensitivity of CCT, particularly as it compares to TEE. The evidence discussed below reveals that TEE is generally superior for the detection of vegetation, owing to its greater temporal resolution, while CCT can provide comparable or better diagnostic accuracy in the evaluation of paravalvular complications. <xref rid="fig2-17539447241305587" ref-type="fig">Figure 2</xref> highlights how these modalities can complement one another and provide different clinical information.</p><fig position="float" id="fig2-17539447241305587" orientation="portrait"><label>Figure 2.</label><caption><p>Fifty-four-year-old man with a history of bacterial endocarditis and subsequent valve homograft implantation presenting with 3&#8201;weeks of fatigue. Transesophageal echocardiography (mid-esophageal short-axis view) shows a homograft prosthetic aortic valve with a large pseudoaneurysm/abscess cavity from the left coronary sinus (a, *) with abnormal flow on color Doppler (b). A large mobile vegetation with multiple fronds (arrow) is also seen inside the abscess cavity. A gated cardiac CT further defines the consequences of the infection. Sagittal images during diastole (c) and systole (d) show dynamic compression (circle) of the left main coronary artery between the pulmonary artery and the pseudoaneurysm cavity. Axial view (e) more clearly shows the extension of the large pseudoaneurysm from the left coronary sinus communicating with the left ventricle along the lateral wall (*). The large vegetation is again seen by CT (arrow).</p><p>CT, computed tomography.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="10.1177_17539447241305587-fig2.jpg"/></fig><p>In a 75-patient 2018 study by Kim et&#8239;al., the detection rate for vegetations was found to be higher in TEE compared to CCT (97.3% and 72.0%, respectively), noting that small vegetations under 10&#8201;mm were more often underdiagnosed with CCT compared to TEE (52.2% vs 94.4%).<sup>
<xref rid="bibr51-17539447241305587" ref-type="bibr">51</xref>
</sup> Sims et&#8239;al. published a retrospective review of 137 patients with IE and reported a sensitivity of 70% for vegetation detection using CCT when compared to surgical findings.<sup>
<xref rid="bibr52-17539447241305587" ref-type="bibr">52</xref>
</sup> In a large 872-patient contemporary meta-analysis, a similar pattern was found, with a vegetation detection sensitivity of 96% and 85% for TEE and CCT, respectively, noting that in the PVIE subgroup, CCT in fact had higher specificity compared to TEE (94% vs 74%).<sup>
<xref rid="bibr53-17539447241305587" ref-type="bibr">53</xref>
</sup></p><p>With regard to paravalvular complications, the same study above by Jain et&#8239;al. found comparable diagnostic performance between CCT and TEE for detecting fistulae, paravalvular leaks, and prosthetic valve dehiscence, with a trend favoring CCT for detection of paravalvular complications and TEE for leaflet perforation.<sup>
<xref rid="bibr53-17539447241305587" ref-type="bibr">53</xref>
</sup> Other studies found that CCT could be superior to TEE for the evaluation of paravalvular complications in certain clinical cases. Sifaoui et&#8239;al. published a 68-patient study of left-sided PVIE and NVIE, and found CCT to be more sensitive than TEE in pseudoaneurysm detection (100% vs 67%).<sup>
<xref rid="bibr54-17539447241305587" ref-type="bibr">54</xref>
</sup> In a 122-patient study with surgically proven IE, sensitivity and specificity for pseudoaneurysm/abscess detection were greater with CCT compared to TEE (81% vs 64% and 75% vs 33%, respectively).<sup>
<xref rid="bibr55-17539447241305587" ref-type="bibr">55</xref>
</sup> Another retrospective study published in 2018 by Ouchi et&#8239;al. found that CCT again offered superior pseudoaneurysm detection in a cohort of surgically proven IE.<sup>
<xref rid="bibr56-17539447241305587" ref-type="bibr">56</xref>
</sup> Importantly, and especially relevant for clinical practice, several of the studies listed above have also found that the combination of CCT with TEE can significantly improve diagnostic yield, with an increased sensitivity of approximately 15% when combining imaging modalities.<sup><xref rid="bibr53-17539447241305587" ref-type="bibr">53</xref>,<xref rid="bibr55-17539447241305587" ref-type="bibr">55</xref>,<xref rid="bibr57-17539447241305587" ref-type="bibr">57</xref></sup> In addition to relatively lower temporal resolution resulting in poorer detection of small vegetations and leaflet perforation, CCT has several important limitations that clinicians must remember. Radiation exposure can be high, particularly in the retrospective, four-dimensional ECG-gated protocols generally used for IE. Several techniques can be used to minimize radiation like tube current reduction and iterative reconstruction; however, these measures can affect the assessment of mobile vegetation and cardiac valves.<sup>
<xref rid="bibr47-17539447241305587" ref-type="bibr">47</xref>
</sup> Nephrotoxicity secondary to dye use is a concern, although typically more so for patients with estimated glomerular filtration rates under 30&#8201;mL/min/1.73&#8201;m.<sup>
<xref rid="bibr47-17539447241305587" ref-type="bibr">47</xref>
</sup> Image acquisition can also be challenging in critically ill patients who may be tachycardic and unable to perform a breath-hold, making patient selection and heart rate control to ensure good diagnostic accuracy very important.<sup>
<xref rid="bibr58-17539447241305587" ref-type="bibr">58</xref>
</sup> The technology of photon counting has led to improvement in spatial resolution in the diagnosis of IE. This is an advanced feature that is evolving and has an advantage over the traditional energy-integrating dual-source scanners. Scanners with the ability to perform photon counting have better spatial resolution which could expand the role of CCT in IE<sup>
<xref rid="bibr58-17539447241305587" ref-type="bibr">58</xref>
</sup> (<xref rid="table1-17539447241305587" ref-type="table">Table1</xref>).</p></sec></sec><sec id="section13-17539447241305587"><title>Summary</title><p>CCT plays a major role in evaluating paravalvular complications, while TEE is superior in detecting vegetation. It also has higher sensitivity in detecting pseudoaneurysms and abscesses compared to TEE.</p></sec><sec id="section14-17539447241305587"><title>Nuclear imaging in IE</title><sec id="section15-17539447241305587"><title>Technical aspects</title><p>The addition of hybrid nuclear medicine imaging modalities such as <sup>18</sup>F-FDG PET/CT has been very valuable as a complementary tool in the evaluation of endocarditis. The basis of FDG-PET lies in the use of <sup>18</sup>F-FDG, a radioactive analog of glucose, which preferentially enters cells with high glucose transporter membrane expression and therefore high metabolic activity.<sup>
<xref rid="bibr59-17539447241305587" ref-type="bibr">59</xref>
</sup> The formation of biofilm is also common on prosthetic material and renders it more metabolically active. Understanding this fundamental principle is key, as it may explain why <sup>18</sup>F-FDG PET/CT has been particularly effective in evaluating PVIE and infection of other synthetic materials, including CIED and infected aortic grafts, but less so for NVIE.</p></sec><sec id="section16-17539447241305587"><title>Indications according to different guidelines</title><p>Recently updated ESC guidelines now recommend the use of <sup>18</sup>F-FDG PET/CT in the diagnostic algorithms of NVIE, PVIE, and CIED-IE.<sup>
<xref rid="bibr6-17539447241305587" ref-type="bibr">6</xref>
</sup> Abnormal cardiac findings typical of IE are considered a major imaging criterion in both the 2023 ESC and 2023 Duke-ISCVI diagnostic criteria.<sup><xref rid="bibr5-17539447241305587" ref-type="bibr">5</xref>,<xref rid="bibr30-17539447241305587" ref-type="bibr">30</xref></sup> It should be noted that in patients with a valvular prosthesis implanted less than 3&#8201;months, positive <sup>18</sup>F-FDG PET/CT findings are only considered a minor criterion in the 2023 Duke classification.<sup>
<xref rid="bibr5-17539447241305587" ref-type="bibr">5</xref>
</sup></p><p>The ACC/AHA guidelines, in contrast, have yet to make a formal recommendation on its routine use despite acknowledging its diagnostic utility.<sup>
<xref rid="bibr7-17539447241305587" ref-type="bibr">7</xref>
</sup></p></sec><sec id="section17-17539447241305587"><title>Sensitivity, specificity, and limitations</title><p>In a retrospective study of 303 patients, the sensitivity of <sup>18</sup>F-FDG PET/CT was noted to be much higher in PVIE (93%) compared to NVIE (22%); on review of histopathologic findings, the NVIE group was found to have a significantly lower number of polymorphonuclear cells and higher tissue fibrosis extent, conferring a lesser localized inflammatory process consistent with the reduced <sup>18</sup>F-FDG uptake observed in these patients.<sup>
<xref rid="bibr60-17539447241305587" ref-type="bibr">60</xref>
</sup> In a meta-analysis of seven largely prospective studies, Kamani et&#8239;al. similarly showed quite a low sensitivity (36.9%) albeit excellent specificity (99.1%) for the diagnosis of NVIE using <sup>18</sup>F-FDG PET/CT.<sup>
<xref rid="bibr59-17539447241305587" ref-type="bibr">59</xref>
</sup> Even in those studies where patient preparation for the scan and myocardial glucose uptake suppression were optimized such that sensitivity reached a high of 80%,<sup>
<xref rid="bibr61-17539447241305587" ref-type="bibr">61</xref>
<sup>18</sup>
</sup>F-FDG PET/CT continued to prove less sensitive for NVIE than traditional imaging modalities such as TEE. The role of <sup>18</sup>F-FDG PET/CT therefore remains limited in evaluating for NVIE but should be considered if there remains equipoise for the diagnosis or if TEE cannot be performed.</p><p>In the evaluation of PVIE, several studies have demonstrated that the addition of <sup>18</sup>F-FDG PET/CT can help improve diagnostic assessment. In a pooled meta-analysis of 28 studies totaling 1358 patients, the sensitivity for diagnosing PVIE using <sup>18</sup>F-FDG PET/CT was 86% with a concomitant specificity of 84%.<sup>
<xref rid="bibr62-17539447241305587" ref-type="bibr">62</xref>
</sup> Similar findings have been reproduced across several studies. In a 72-patient prospective study by Saby et&#8239;al., the scan sensitivity for PVIE was 73%, and it was found that adding abnormal FDG uptake around the prosthetic valve as a diagnostic criterion increased the sensitivity of the classically used modified Duke Criteria from 70% to 97%.<sup>
<xref rid="bibr63-17539447241305587" ref-type="bibr">63</xref>
</sup> The 188-patient study by de Camargo et&#8239;al. likewise included <sup>18</sup>F-FDG cardiac uptake as a major criterion at admission and recategorized 76% of its patients from &#8220;possible&#8221; to &#8220;definite&#8221; PVIE.<sup>
<xref rid="bibr60-17539447241305587" ref-type="bibr">60</xref>
</sup></p><p>The use of <sup>18</sup>F-FDG PET/CT has also been of interest in cases of CIED, albeit with a wide range of reported sensitivity from 16.3% in the EURO-ENDO registry<sup>
<xref rid="bibr16-17539447241305587" ref-type="bibr">16</xref>
</sup> to 76.2% in the large meta-analysis by Wang et&#8239;al.<sup>
<xref rid="bibr62-17539447241305587" ref-type="bibr">62</xref>
</sup> This may be explained by the distinction in test sensitivity between the intracardiac and extracardiac components of the device, with much lower sensitivity in detecting lead infection compared to pocket infection as noted in both single-center studies and meta-analyses.<sup><xref rid="bibr64-17539447241305587" ref-type="bibr">64</xref>,<xref rid="bibr65-17539447241305587" ref-type="bibr">65</xref>
<sup>18</sup></sup>F-FDG PET/CT has also proved useful in the evaluation of vascular graft infections, which can be difficult to diagnose clinically given the nonspecific symptoms and often negative serum microbiology. Mikail et&#8239;al. showed the benefit of combining FDG-PET and CTA in a four-patient case series.<sup>
<xref rid="bibr66-17539447241305587" ref-type="bibr">66</xref>
</sup> Interestingly, a meta-analysis combining 13 studies found that the pattern of FDG uptake rather than its presence and intensity was an important diagnostic tool for aortic graft infection evaluation.<sup>
<xref rid="bibr67-17539447241305587" ref-type="bibr">67</xref>
</sup> Lastly, in addition to extracardiac CIED-IE, the presence of extracardiac foci of infection can be determined with <sup>18</sup>F-FDG PET/CT<sup>
<xref rid="bibr68-17539447241305587" ref-type="bibr">68</xref>
<xref rid="bibr68-17539447241305587" ref-type="bibr"/>
</sup> and it could be useful in excluding IE, which can have important clinical implications; in a 40-patient study by Orvin et&#8239;al., detection of extracardiac complications was shown to affect treatment planning in 35% of cases, including a 15% increase in surgical referrals.<sup>
<xref rid="bibr69-17539447241305587" ref-type="bibr">69</xref>
</sup> Duval et&#8239;al. investigated the impact of systematic whole body <sup>18</sup>F-FDG PET/CT on the management of patients suspected of IE including 70 suspected PVIE patients and 70 suspected NVIE patients. Management was modified in 21.4% of patients with PVIE and 31% of patients with NVIE (<italic toggle="yes">p</italic>&#8201;=&#8201;0.005) mainly due to paravalvular uptake in patients with PVIE and extracardiac uptake in patients with NVIE.<sup>
<xref rid="bibr70-17539447241305587" ref-type="bibr">70</xref>
</sup></p><p>The value of <sup>18</sup>F-FDG/CT was also tested in the era of machine learning. Godefroy et&#8239;al. evaluated 108 patients retrospectively from a single center between 2015 and 2021 with suspected aortic PVIE. <sup>18</sup>F-FDG/CT machine learning-based analysis had 59% sensitivity and 83% specificity in detecting aortic PVIE.<sup>
<xref rid="bibr71-17539447241305587" ref-type="bibr">71</xref>
</sup></p><p>Key limitations to <sup>18</sup>F-FDG PET/CT should be considered. Patients in the early postoperative period, particularly the first several months of a prosthetic valve or graft implantation, may have an FDG-avid result at the surgical site, which may not correlate with infection but rather with expected ongoing inflammation. <xref rid="fig3-17539447241305587" ref-type="fig">Figure 3</xref> highlights the difference between low-level FDG uptake in a normal surgical graft and the high-intensity, heterogeneous uptake in an infected graft. In a 39-patient study by Rouzet et&#8239;al., the majority of patients who had false-positive findings by FDG-PET were in fact within 2&#8201;months of their cardiac surgery; intensity of FDG-avidity was noted to wane with time but could still persist years after the surgery.<sup>
<xref rid="bibr72-17539447241305587" ref-type="bibr">72</xref>
</sup> For this reason, 2015 ESC and 2023 Duke-ISCVID guidelines do not recommend PET within 3&#8201;months of valve implantation.<sup>
<xref rid="bibr6-17539447241305587" ref-type="bibr">6</xref>
</sup> Interestingly, Swart et&#8239;al. published a multi-center trial in which recent valve implantation was not found to be a predictor of false-positive results, but the use of surgical adhesives was.<sup>
<xref rid="bibr73-17539447241305587" ref-type="bibr">73</xref>
</sup> Biologic adhesives such as Bioglu<sup>&#174;</sup> were also reported as a cause of false positives in integrated PET/CT.<sup>
<xref rid="bibr74-17539447241305587" ref-type="bibr">74</xref>
</sup> Other inflammatory processes like vasculitis, myocarditis, malignancy, and even atherosclerotic or thrombotic plaque may also cause a false-positive result.<sup>
<xref rid="bibr71-17539447241305587" ref-type="bibr">71</xref>
</sup> Conversely, patients who have been on prolonged antibiotics may have a decreased FDG signal owing to the lower inflammatory activity resulting in a false negative study, making the timing of <sup>18</sup>F-FDG PET/CT implementation critical.<sup>
<xref rid="bibr70-17539447241305587" ref-type="bibr">70</xref>
</sup> Lastly, PET imaging requires dedicated expertise for interpretation, specialized equipment, and strict oral intake preparation, which has limited its widespread use and availability.</p><fig position="float" id="fig3-17539447241305587" orientation="portrait"><label>Figure 3.</label><caption><p>Whole body <sup>18</sup>F-FDG PET/CT of a patient with prior aortic root, ascending aorta, and arch replacement and aorto-bifemoral bypass graft, presenting with fevers and methicillin-sensitive <italic toggle="yes">Staphylococcus aureus</italic> (MSSA) bacteremia. Note the intense heterogeneous uptake in the ascending aorta graft consistent with infection (a, blue arrows), in comparison to low-level more homogeneous uptake in the abdominal graft (b, green arrow) consistent with expected post-surgical changes.</p><p>MSSA, methicillin-sensitive <italic toggle="yes">Staphylococcus aureus</italic>.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="10.1177_17539447241305587-fig3.jpg"/></fig></sec></sec><sec id="section18-17539447241305587"><title>Summary</title><p><sup>
<xref rid="bibr18-17539447241305587" ref-type="bibr">18</xref>
</sup>F-FDG PET/CT has higher sensitivity in patients with PVIE. It should not be routinely performed in patients with NVIE and only be considered in patients who are unable to have a TEE. It has great value in detecting vascular graft infections. Its role in CIED-ID is limited due to low sensitivity. Finally, it plays an important role in detecting extracardiac foci of infection which could be useful in excluding IE.</p></sec><sec id="section19-17539447241305587"><title>Radiolabeled-WBC SPECT/CT in IE</title><sec id="section20-17539447241305587"><title>Technical aspects</title><p>Similar to <sup>18</sup>F-FDG PET/CT, WBC scintigraphy with hybrid SPECT/CT imaging utilizes radiolabeled white blood cells with the understanding that increased uptake of the cells will preferentially be directed toward infected tissues, there is actually more limited data on WBC scintigraphy for IE, largely restricted to single-center trials and case series.</p></sec><sec id="section21-17539447241305587"><title>Indications according to different guidelines</title><p>The use of WBC-SPECT/CT should be considered in patients with high clinical suspicion of PVIE or cardiac implanted devices when echocardiography is negative or inconclusive, and when <sup>18</sup>F-FDG PET/CT is not available.<sup><xref rid="bibr3-17539447241305587" ref-type="bibr">3</xref>,<xref rid="bibr4-17539447241305587" ref-type="bibr">4</xref></sup></p></sec><sec id="section22-17539447241305587"><title>Sensitivity, specificity, and limitations</title><p>One of the first studies to demonstrate the utility of WBC scintigraphy in IE was a 131-patient study by Erba et&#8239;al., which showed a 90% sensitivity, 94% negative predictive value, and 100% specificity and positive predictive value in using scintigraphy for IE; both NVIE and PVIE were included.<sup>
<xref rid="bibr76-17539447241305587" ref-type="bibr">76</xref>
</sup> Interestingly, there were no false-positive results in the study, even in patients who were in the early 2-month postoperative period.<sup>
<xref rid="bibr72-17539447241305587" ref-type="bibr">72</xref>
</sup> False-negative findings were hypothesized to be secondary to the organism type such as <italic toggle="yes">Candida</italic> or <italic toggle="yes">Enterococcus</italic> species that may form biofilm or produce proteases to minimize leukocyte infiltration.<sup>
<xref rid="bibr72-17539447241305587" ref-type="bibr">72</xref>
</sup> In a later study by Rouzet et&#8239;al., 39 patients were evaluated with both <sup>18</sup>F-FDG PET/CT and WBC scintigraphy; the former modality was found to have sensitivity and specificity of 93% and 71%, while the latter had a lower sensitivity of 64% but a specificity of 100%, once again demonstrating the discriminatory power of WBC scintigraphy in the early postoperative period (in the first 2&#8201;months after surgery), but the higher false-negative rate with non-pyogenic microorganisms (such as Coxiella or Candida).<sup>
<xref rid="bibr72-17539447241305587" ref-type="bibr">72</xref>
</sup> A retrospective French study comprising 36 patients who underwent cardiac surgery 30&#8201;days after WBC-SPECT imaging noted similar sensitivity and specificity of 87% and 100%, and found that patients with negative imaging were more likely to have a longer antibiotic duration and absence of perivalvular abscess.<sup>
<xref rid="bibr73-17539447241305587" ref-type="bibr">73</xref>
</sup></p><p>Data on CIED-IE specifically are limited with this modality, but one study by Holcman et&#8239;al. found that tagged WBC-SPECT/CT could help reclassify patients with possible CIED-IE and increase original modified Duke criteria accuracy from 83% to 88%.<sup>
<xref rid="bibr78-17539447241305587" ref-type="bibr">78</xref>
</sup> In another study by Erba et&#8239;al., 63 patients with suspected CIED-IE underwent WBC scintigraphy, which had a sensitivity of 94% and specificity of 100%.<sup>
<xref rid="bibr75-17539447241305587" ref-type="bibr">75</xref>
</sup> Several small studies of patients with suspected LVAD infections also reported 100% specificity in using WBC scintigraphy,<sup><xref rid="bibr76-17539447241305587" ref-type="bibr">76</xref>,<xref rid="bibr77-17539447241305587" ref-type="bibr">77</xref></sup> with one study noting a sensitivity of 71.4%. In a small 23-patient study of endovascular grafts where patients routinely underwent WBC scintigraphy, there were no false positives in the first month after prosthesis implantation.<sup>
<xref rid="bibr78-17539447241305587" ref-type="bibr">78</xref>
</sup> Taken together, these data highlight the potential utility of radiolabeled WBC SPECT/CT, particularly in cases of clinical equipoise where echocardiography is limited and <sup>18</sup>F-FDG PET/CT may yield false-positive results in the early postoperative setting.</p></sec></sec><sec id="section23-17539447241305587"><title>Summary</title><p><sup>
<xref rid="bibr18-17539447241305587" ref-type="bibr">18</xref>
</sup>F-FDG PET/CT has higher sensitivity in patients with PVIE. It should not be routinely performed in patients with NVIE and only be considered in patients who are unable to have a TEE. It has great value in detecting vascular graft infections. Its role in CIED-ID is limited due to low sensitivity. Finally, it plays an important role in detecting extracardiac foci of infection which could be useful in excluding IE.</p><sec id="section24-17539447241305587"><title>MRI in IE</title><p>While the use of brain MRI to evaluate for subclinical embolization events can allow for early diagnosis of IE and affect treatment strategy,<sup>
<xref rid="bibr79-17539447241305587" ref-type="bibr">79</xref>
</sup> the use of cardiac MRI has a less well-defined role in the evaluation of IE.<sup>
<xref rid="bibr6-17539447241305587" ref-type="bibr">6</xref>
</sup> Only small single-center studies have evaluated the diagnostic potential of cardiac magnetic resonance (CMR), and with limited direct comparison to other imaging modalities. Dursun et&#8239;al. published a 16-patient study that showed CMR could detect 14 vegetations in 11 patients, in addition to detecting endothelial inflammation of cardiac structures via late gadolinium enhancement (LGE) imaging.<sup>
<xref rid="bibr84-17539447241305587" ref-type="bibr">84</xref>
</sup> A study by Zatorska et&#8239;al. noted that LGE was present in up to 40% of their 20 patients, and often extended into the myocardium itself.<sup>
<xref rid="bibr85-17539447241305587" ref-type="bibr">85</xref>
</sup> The study also highlighted the limited spatial resolution of CMR that made vegetation detection inferior to echocardiography.<sup>
<xref rid="bibr81-17539447241305587" ref-type="bibr">81</xref>
</sup> Bhuta et&#8239;al. built on these earlier findings and reported on a 14-patient study, where CMR failed to identify vegetations readily seen by echocardiography in two patients.<sup>
<xref rid="bibr86-17539447241305587" ref-type="bibr">86</xref>
</sup> They also found the diagnostic accuracy of CMR was significantly affected by a patient with a prosthetic aortic valve.<sup>
<xref rid="bibr82-17539447241305587" ref-type="bibr">82</xref>
</sup> They too found evidence of LGE in several of their patients but noted that these findings did not ultimately help guide clinical decision-making.<sup>
<xref rid="bibr82-17539447241305587" ref-type="bibr">82</xref>
</sup></p><p>The present data suggest that CMR has a limited role as a primary diagnostic modality in the evaluation of IE. It should be highlighted that CMR can provide valuable information on cardiac anatomy, valvular function, hemodynamic assessment, myo-pericardial inflammatory status, and mass characterization.<sup>
<xref rid="bibr82-17539447241305587" ref-type="bibr">82</xref>
</sup> However, CMR is a timely and costly tool that is generally limited to specialized centers with larger volumes of patient cases and expertise on appropriate imaging protocols.<sup>
<xref rid="bibr82-17539447241305587" ref-type="bibr">82</xref>
</sup> As was noted in some of the above studies, even in specialized centers, CMR evaluation can be significantly affected by magnetic artifacts from prosthetic valves or CIEDs, as well as patient factors including poorly controlled heart rates and inability to perform breath-holds.<sup><xref rid="bibr71-17539447241305587" ref-type="bibr">71</xref>,<xref rid="bibr82-17539447241305587" ref-type="bibr">82</xref></sup> As this imaging modality continues to evolve, spatial and temporal resolution are likely to improve and CMR may find a greater role in the evaluation of IE in the future, particularly when used in conjunction with other imaging modalities.<sup><xref rid="bibr83-17539447241305587" ref-type="bibr">83</xref><xref rid="bibr84-17539447241305587" ref-type="bibr"/><xref rid="bibr85-17539447241305587" ref-type="bibr"/><xref rid="bibr86-17539447241305587" ref-type="bibr"/>&#8211;<xref rid="bibr87-17539447241305587" ref-type="bibr">87</xref></sup></p></sec></sec><sec sec-type="conclusions" id="section25-17539447241305587"><title>Conclusion</title><p>IE is a serious infection with elevated morbidity and mortality. The role of multimodality imaging in the evaluation of IE continues to evolve, and clinicians should familiarize themselves with the advantages and limitations of these modalities as they pertain to NVIE, PVIE, and other cardiac implantable device- and graft-associated infections to improve the diagnosis and management of patients with IE.</p></sec></body><back><ack><p>None.</p></ack><fn-group><fn fn-type="other"><p><bold>ORCID iD:</bold> Bo Xu <inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="10.1177_17539447241305587-img1.jpg"/>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://orcid.org/0000-0002-2985-7468" ext-link-type="uri">https://orcid.org/0000-0002-2985-7468</ext-link></p></fn></fn-group><sec id="section26-17539447241305587"><title>Declarations</title><fn-group><fn fn-type="other"><p><bold>Ethics approval and consent to participate:</bold> Not applicable, as this is a review article, formal institutional review board approval and informed consent are not required.</p></fn><fn fn-type="other"><p><bold>Consent for publication:</bold> All authors have agreed to the publication of this article.</p></fn><fn fn-type="con"><p><bold>Author contributions:</bold>
<bold>Alice Haouzi:</bold> Data curation; Formal analysis; Investigation; Methodology; Validation; Writing &#8211; original draft.</p><p><bold>Mohamed Khayata:</bold> Data curation; Formal analysis; Methodology; Writing &#8211; original draft.</p><p><bold>Bo Xu:</bold> Conceptualization; Formal analysis; Investigation; Methodology; Resources; Supervision; Visualization; Writing &#8211; review &amp; editing.</p></fn><fn fn-type="financial-disclosure"><p><bold>Funding:</bold> The authors received no financial support for the research, authorship, and/or publication of this article.</p></fn><fn fn-type="COI-statement"><p>The authors declare that there is no conflict of interest.</p></fn><fn fn-type="other"><p><bold>Availability of data and materials:</bold> Not applicable, as this is a review article.</p></fn></fn-group></sec><ref-list><title>References</title><ref id="bibr1-17539447241305587"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cahill</surname><given-names>TJ</given-names></name><name name-style="western"><surname>Prendergast</surname><given-names>BD.</given-names></name></person-group><article-title>Infective endocarditis</article-title>. <source>Lancet</source><year>2016</year>; <volume>387</volume>(<issue>10021</issue>): <fpage>882</fpage>&#8211;<lpage>893</lpage>.<pub-id pub-id-type="pmid">26341945</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S0140-6736(15)00067-7</pub-id></mixed-citation></ref><ref id="bibr2-17539447241305587"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Murray</surname><given-names>CJL</given-names></name><name name-style="western"><surname>Vos</surname><given-names>T</given-names></name><name name-style="western"><surname>Lozano</surname><given-names>R</given-names></name></person-group>, <etal>et al</etal>. <article-title>Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990&#8211;2010: a systematic analysis for the Global Burden of Disease Study 2010</article-title>. <source>Lancet</source><year>2012</year>; <volume>380</volume>(<issue>9859</issue>): <fpage>2197</fpage>&#8211;<lpage>2223</lpage>.<pub-id pub-id-type="pmid">23245608</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S0140-6736(12)61689-4</pub-id></mixed-citation></ref><ref id="bibr3-17539447241305587"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thornhill</surname><given-names>MH</given-names></name><name name-style="western"><surname>Dayer</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Nicholl</surname><given-names>J</given-names></name></person-group>, <etal>et al</etal>. <article-title>An alarming rise in incidence of infective endocarditis in England since 2009: why?</article-title><source>Lancet</source><year>2020</year>; <volume>395</volume>(<issue>10233</issue>): <fpage>1325</fpage>&#8211;<lpage>1327</lpage>.<pub-id pub-id-type="pmid">32334690</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S0140-6736(20)30530-4</pub-id></mixed-citation></ref><ref id="bibr4-17539447241305587"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Talha</surname><given-names>KM</given-names></name><name name-style="western"><surname>Baddour</surname><given-names>LM</given-names></name><name name-style="western"><surname>Thornhill</surname><given-names>MH</given-names></name></person-group>, <etal>et al</etal>. <article-title>Escalating incidence of infective endocarditis in Europe in the 21st century</article-title>. <source>Open Heart</source><year>2021</year>; <volume>8</volume>(<issue>2</issue>): e001846.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/openhrt-2021-001846</pub-id><pub-id pub-id-type="pmcid">PMC8529987</pub-id><pub-id pub-id-type="pmid">34670832</pub-id></mixed-citation></ref><ref id="bibr5-17539447241305587"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chobufo</surname><given-names>MD</given-names></name><name name-style="western"><surname>Atti</surname><given-names>V</given-names></name><name name-style="western"><surname>Vasudevan</surname><given-names>A</given-names></name></person-group>, <etal>et al</etal>. <article-title>Trends in infective endocarditis mortality in the United States: 1999 to 2020: a cause for alarm</article-title>. <source>J Am Heart Assoc</source><year>2023</year>; <volume>12</volume>(<issue>24</issue>): e031589.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/JAHA.123.031589</pub-id><pub-id pub-id-type="pmcid">PMC10863783</pub-id><pub-id pub-id-type="pmid">38088249</pub-id></mixed-citation></ref><ref id="bibr6-17539447241305587"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Delgado</surname><given-names>V</given-names></name><name name-style="western"><surname>Ajmone Marsan</surname><given-names>N</given-names></name><name name-style="western"><surname>de Waha</surname><given-names>S</given-names></name></person-group>, <etal>et al</etal>. <article-title>2023 ESC Guidelines for the management of endocarditis</article-title>. <source>Eur Heart J</source><year>2023</year>; <volume>44</volume>(<issue>39</issue>): <fpage>3948</fpage>&#8211;<lpage>4042</lpage>.<pub-id pub-id-type="pmid">37622656</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/eurheartj/ehad193</pub-id></mixed-citation></ref><ref id="bibr7-17539447241305587"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Otto</surname><given-names>CM</given-names></name><name name-style="western"><surname>Nishimura</surname><given-names>RA</given-names></name><name name-style="western"><surname>Bonow</surname><given-names>RO</given-names></name></person-group>, <etal>et al</etal>. <article-title>2020 ACC/AHA guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines</article-title>. <source>Circulation</source><year>2021</year>; <volume>143</volume>(<issue>5</issue>): e35&#8211;e71.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/CIR.0000000000000932</pub-id><pub-id pub-id-type="pmid">33332149</pub-id></mixed-citation></ref><ref id="bibr8-17539447241305587"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alkhouli</surname><given-names>M</given-names></name><name name-style="western"><surname>Alqahtani</surname><given-names>F</given-names></name><name name-style="western"><surname>Alhajji</surname><given-names>M</given-names></name></person-group>, <etal>et al</etal>. <article-title>Clinical and economic burden of hospitalizations for infective endocarditis in the United States</article-title>. <source>Mayo Clin Proc</source><year>2020</year>; <volume>95</volume>(<issue>5</issue>): <fpage>858</fpage>&#8211;<lpage>866</lpage>.<pub-id pub-id-type="pmid">31902529</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.mayocp.2019.08.023</pub-id></mixed-citation></ref><ref id="bibr9-17539447241305587"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gomes</surname><given-names>A</given-names></name><name name-style="western"><surname>Glaudemans</surname><given-names>AWJM</given-names></name><name name-style="western"><surname>Touw</surname><given-names>DJ</given-names></name></person-group>, <etal>et al</etal>. <article-title>Diagnostic value of imaging in infective endocarditis: a systematic review</article-title>. <source>Lancet Infect Dis</source><year>2017</year>; <volume>17</volume>(<issue>1</issue>): e1&#8211;e14.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S1473-3099(16)30141-4</pub-id><pub-id pub-id-type="pmid">27746163</pub-id></mixed-citation></ref><ref id="bibr10-17539447241305587"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Khayata</surname><given-names>M</given-names></name><name name-style="western"><surname>Hackney</surname><given-names>N</given-names></name><name name-style="western"><surname>Addoumieh</surname><given-names>A</given-names></name></person-group>, <etal>et al</etal>. <article-title>Impact of opioid epidemic on infective endocarditis outcomes in the United States: from the national readmission database</article-title>. <source>Am J Cardiol</source><year>2022</year>; <volume>183</volume>: <fpage>137</fpage>&#8211;<lpage>142</lpage>.<pub-id pub-id-type="pmid">36085056</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.amjcard.2022.08.002</pub-id></mixed-citation></ref><ref id="bibr11-17539447241305587"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baddour</surname><given-names>LM</given-names></name><name name-style="western"><surname>Wilson</surname><given-names>WR</given-names></name><name name-style="western"><surname>Bayer</surname><given-names>AS</given-names></name></person-group>, <etal>et al</etal>. <article-title>Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association</article-title>. <source>Circulation</source><year>2015</year>; <volume>132</volume>(<issue>15</issue>): <fpage>1435</fpage>&#8211;<lpage>1486</lpage>.<pub-id pub-id-type="pmid">26373316</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/CIR.0000000000000296</pub-id></mixed-citation></ref><ref id="bibr12-17539447241305587"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Murdoch</surname><given-names>DR</given-names></name><name name-style="western"><surname>Corey</surname><given-names>GR</given-names></name><name name-style="western"><surname>Hoen</surname><given-names>B</given-names></name></person-group>, <etal>et al</etal>. <article-title>Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study</article-title>. <source>Arch Intern Med</source><year>2009</year>; <volume>169</volume>(<issue>5</issue>): <fpage>463</fpage>&#8211;<lpage>473</lpage>.<pub-id pub-id-type="pmid">19273776</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/archinternmed.2008.603</pub-id><pub-id pub-id-type="pmcid">PMC3625651</pub-id></mixed-citation></ref><ref id="bibr13-17539447241305587"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rajani</surname><given-names>R</given-names></name><name name-style="western"><surname>Klein</surname><given-names>JL.</given-names></name></person-group><article-title>Infective endocarditis: a contemporary update</article-title>. <source>Clin Med (Lond)</source><year>2020</year>; <volume>20</volume>(<issue>1</issue>): <fpage>31</fpage>&#8211;<lpage>35</lpage>.<pub-id pub-id-type="pmid">31941729</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.7861/clinmed.cme.20.1.1</pub-id><pub-id pub-id-type="pmcid">PMC6964163</pub-id></mixed-citation></ref><ref id="bibr14-17539447241305587"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bin Abdulhak</surname><given-names>AA</given-names></name><name name-style="western"><surname>Baddour</surname><given-names>LM</given-names></name><name name-style="western"><surname>Erwin</surname><given-names>PJ</given-names></name></person-group>, <etal>et al</etal>. <article-title>Global and regional burden of infective endocarditis, 1990&#8211;2010: a systematic review of the literature</article-title>. <source>Glob Heart</source><year>2014</year>; <volume>9</volume>(<issue>1</issue>): <fpage>131</fpage>&#8211;<lpage>143</lpage>.<pub-id pub-id-type="pmid">25432123</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.gheart.2014.01.002</pub-id></mixed-citation></ref><ref id="bibr15-17539447241305587"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>A</given-names></name><name name-style="western"><surname>Athan</surname><given-names>E</given-names></name><name name-style="western"><surname>Pappas</surname><given-names>PA</given-names></name></person-group>, <etal>et al</etal>. <article-title>Contemporary clinical profile and outcome of prosthetic valve endocarditis</article-title>. <source>JAMA</source><year>2007</year>; <volume>297</volume>(<issue>12</issue>): <fpage>1354</fpage>&#8211;<lpage>1361</lpage>.<pub-id pub-id-type="pmid">17392239</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jama.297.12.1354</pub-id></mixed-citation></ref><ref id="bibr16-17539447241305587"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sharma</surname><given-names>T</given-names></name><name name-style="western"><surname>Krishnan</surname><given-names>AM</given-names></name><name name-style="western"><surname>Lahoud</surname><given-names>R</given-names></name></person-group>, <etal>et al</etal>. <article-title>National trends in TAVR and SAVR for patients with severe isolated aortic stenosis</article-title>. <source>J Am Coll Cardiol</source><year>2022</year>; <volume>80</volume>(<issue>21</issue>): <fpage>2054</fpage>&#8211;<lpage>2056</lpage>.<pub-id pub-id-type="pmid">36122626</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jacc.2022.08.787</pub-id></mixed-citation></ref><ref id="bibr17-17539447241305587"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Habib</surname><given-names>G</given-names></name><name name-style="western"><surname>Erba</surname><given-names>PA</given-names></name><name name-style="western"><surname>Iung</surname><given-names>B</given-names></name></person-group>, <etal>et al</etal>. <article-title>Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study</article-title>. <source>Eur Heart J</source><year>2019</year>; <volume>40</volume>(<issue>39</issue>): <fpage>3222</fpage>&#8211;<lpage>3232</lpage>.<pub-id pub-id-type="pmid">31504413</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/eurheartj/ehz620</pub-id></mixed-citation></ref><ref id="bibr18-17539447241305587"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Glaser</surname><given-names>N</given-names></name><name name-style="western"><surname>Jackson</surname><given-names>V</given-names></name><name name-style="western"><surname>Holzmann</surname><given-names>MJ</given-names></name></person-group>, <etal>et al</etal>. <article-title>Prosthetic valve endocarditis after surgical aortic valve replacement</article-title>. <source>Circulation</source><year>2017</year>; <volume>136</volume>(<issue>3</issue>): <fpage>329</fpage>&#8211;<lpage>331</lpage>.<pub-id pub-id-type="pmid">28716834</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/CIRCULATIONAHA.117.028783</pub-id></mixed-citation></ref><ref id="bibr19-17539447241305587"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kusumoto</surname><given-names>FM</given-names></name><name name-style="western"><surname>Schoenfeld</surname><given-names>MH</given-names></name><name name-style="western"><surname>Wilkoff</surname><given-names>BL</given-names></name></person-group>, <etal>et al</etal>. <article-title>2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction</article-title>. <source>Heart Rhythm</source><year>2017</year>; <volume>14</volume>(<issue>12</issue>): e503&#8211;e551.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.hrthm.2017.09.001</pub-id><pub-id pub-id-type="pmid">28919379</pub-id></mixed-citation></ref><ref id="bibr20-17539447241305587"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Donal</surname><given-names>E</given-names></name><name name-style="western"><surname>Tribouilloy</surname><given-names>C</given-names></name><name name-style="western"><surname>Sadeghpour</surname><given-names>A</given-names></name></person-group>, <etal>et al</etal>. <article-title>Cardiac device-related infective endocarditis need for lead extraction whatever the device according to the ESC EORP EURO-ENDO registry</article-title>. <source>Eur Heart J Open</source><year>2023</year>; <volume>3</volume>(<issue>4</issue>): oead064.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/ehjopen/oead064</pub-id><pub-id pub-id-type="pmcid">PMC10351571</pub-id><pub-id pub-id-type="pmid">37465258</pub-id></mixed-citation></ref><ref id="bibr21-17539447241305587"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>B</given-names></name><name name-style="western"><surname>Reyaldeen</surname><given-names>R.</given-names></name></person-group><article-title>Ascending aortic graft infection&#8212;an expanding role for multi-modality cardiac imaging</article-title>. <source>Int J Cardiol</source><year>2021</year>; <volume>333</volume>: <fpage>246</fpage>&#8211;<lpage>248</lpage>.<pub-id pub-id-type="pmid">33794230</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ijcard.2021.03.066</pub-id></mixed-citation></ref><ref id="bibr22-17539447241305587"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shiraev</surname><given-names>T</given-names></name><name name-style="western"><surname>Barrett</surname><given-names>S</given-names></name><name name-style="western"><surname>Heywood</surname><given-names>S</given-names></name></person-group>, <etal>et al</etal>. <article-title>Incidence, management, and outcomes of aortic graft infection</article-title>. <source>Ann Vasc Surg</source><year>2019</year>; <volume>59</volume>: <fpage>73</fpage>&#8211;<lpage>83</lpage>.<pub-id pub-id-type="pmid">31009718</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.avsg.2019.01.027</pub-id></mixed-citation></ref><ref id="bibr23-17539447241305587"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gordon</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Weinberg</surname><given-names>AD</given-names></name><name name-style="western"><surname>Pagani</surname><given-names>FD</given-names></name></person-group>, <etal>et al</etal>. <article-title>Prospective, multicenter study of ventricular assist device infections</article-title>. <source>Circulation</source><year>2013</year>; <volume>127</volume>(<issue>6</issue>): <fpage>691</fpage>&#8211;<lpage>702</lpage>.<pub-id pub-id-type="pmid">23315371</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/CIRCULATIONAHA.112.128132</pub-id><pub-id pub-id-type="pmcid">PMC3695607</pub-id></mixed-citation></ref><ref id="bibr24-17539447241305587"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hoen</surname><given-names>B</given-names></name><name name-style="western"><surname>Duval</surname><given-names>X.</given-names></name></person-group><article-title>Clinical practice. Infective endocarditis</article-title>. <source>N Engl J Med</source><year>2013</year>; <volume>368</volume>(<issue>15</issue>): <fpage>1425</fpage>&#8211;<lpage>1433</lpage>.<pub-id pub-id-type="pmid">23574121</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1056/NEJMcp1206782</pub-id></mixed-citation></ref><ref id="bibr25-17539447241305587"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Habib</surname><given-names>G</given-names></name><name name-style="western"><surname>Lancellotti</surname><given-names>P</given-names></name><name name-style="western"><surname>Erba</surname><given-names>PA</given-names></name></person-group>, <etal>et al</etal>. <article-title>The ESC-EORP EURO-ENDO (European Infective Endocarditis) registry</article-title>. <source>Eur Heart J Qual Care Clin Outcomes</source><year>2019</year>; <volume>5</volume>(<issue>3</issue>): <fpage>202</fpage>&#8211;<lpage>207</lpage>.<pub-id pub-id-type="pmid">30957862</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/ehjqcco/qcz018</pub-id></mixed-citation></ref><ref id="bibr26-17539447241305587"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Selton-Suty</surname><given-names>C</given-names></name><name name-style="western"><surname>C&#233;lard</surname><given-names>M</given-names></name><name name-style="western"><surname>Le Moing</surname><given-names>V</given-names></name></person-group>, <etal>et al</etal>. <article-title>Preeminence of <italic toggle="yes">Staphylococcus aureus</italic> in infective endocarditis: a 1-year population-based survey</article-title>. <source>Clin Infect Dis</source><year>2012</year>; <volume>54</volume>(<issue>9</issue>): <fpage>1230</fpage>&#8211;<lpage>1239</lpage>.<pub-id pub-id-type="pmid">22492317</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/cid/cis199</pub-id></mixed-citation></ref><ref id="bibr27-17539447241305587"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Isaza</surname><given-names>N</given-names></name><name name-style="western"><surname>Shrestha</surname><given-names>NK</given-names></name><name name-style="western"><surname>Gordon</surname><given-names>S</given-names></name></person-group>, <etal>et al</etal>. <article-title>Contemporary outcomes of pulmonary valve endocarditis: a 16-year single centre experience</article-title>. <source>Heart Lung Circ</source><year>2020</year>; <volume>29</volume>(<issue>12</issue>): <fpage>1799</fpage>&#8211;<lpage>1807</lpage>.<pub-id pub-id-type="pmid">32616369</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.hlc.2020.04.015</pub-id></mixed-citation></ref><ref id="bibr28-17539447241305587"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ding</surname><given-names>F</given-names></name><name name-style="western"><surname>Shrestha</surname><given-names>NK</given-names></name><name name-style="western"><surname>Chetrit</surname><given-names>M</given-names></name></person-group>, <etal>et al</etal>. <article-title>Clinical and echocardiographic characteristics of bartonella infective endocarditis: an 8-year single-centre experience in the United States</article-title>. <source>Heart Lung Circ</source><year>2022</year>; <volume>31</volume>(<issue>3</issue>): <fpage>350</fpage>&#8211;<lpage>357</lpage>.<pub-id pub-id-type="pmid">34456130</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.hlc.2021.07.021</pub-id></mixed-citation></ref><ref id="bibr29-17539447241305587"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Habib</surname><given-names>G</given-names></name><name name-style="western"><surname>Derumeaux</surname><given-names>G</given-names></name><name name-style="western"><surname>Avierinos</surname><given-names>JF</given-names></name></person-group>, <etal>et al</etal>. <article-title>Value and limitations of the Duke criteria for the diagnosis of infective endocarditis</article-title>. <source>J Am Coll Cardiol</source><year>1999</year>; <volume>33</volume>(<issue>7</issue>): <fpage>2023</fpage>&#8211;<lpage>2029</lpage>.<pub-id pub-id-type="pmid">10362209</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0735-1097(99)00116-3</pub-id></mixed-citation></ref><ref id="bibr30-17539447241305587"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fowler</surname><given-names>VG</given-names></name><name name-style="western"><surname>Durack</surname><given-names>DT</given-names></name><name name-style="western"><surname>Selton-Suty</surname><given-names>C</given-names></name></person-group>, <etal>et al</etal>. <article-title>The 2023 Duke-International Society for Cardiovascular Infectious Diseases Criteria for infective endocarditis: updating the modified Duke criteria</article-title>. <source>Clin Infect Dis</source><year>2023</year>; <volume>77</volume>(<issue>4</issue>): <fpage>518</fpage>&#8211;<lpage>526</lpage>.<pub-id pub-id-type="pmid">37138445</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/cid/ciad271</pub-id><pub-id pub-id-type="pmcid">PMC10681650</pub-id></mixed-citation></ref><ref id="bibr31-17539447241305587"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Goehringer</surname><given-names>F</given-names></name><name name-style="western"><surname>Lallou&#233;</surname><given-names>B</given-names></name><name name-style="western"><surname>Selton-Suty</surname><given-names>C</given-names></name></person-group>, <etal>et al</etal>. <article-title>Compared performance of the 2023 Duke-International Society for Cardiovascular Infectious Diseases, 2000 modified Duke, and 2015 European Society of Cardiology criteria for the diagnosis of infective endocarditis in a French multicenter prospective cohort</article-title>. <source>Clin Infect Dis</source><year>2024</year>; <volume>78</volume>(<issue>4</issue>): <fpage>937</fpage>&#8211;<lpage>948</lpage>.<pub-id pub-id-type="pmid">38330171</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/cid/ciae035</pub-id></mixed-citation></ref><ref id="bibr32-17539447241305587"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Haq</surname><given-names>IU</given-names></name><name name-style="western"><surname>Haq</surname><given-names>I</given-names></name><name name-style="western"><surname>Griffin</surname><given-names>B</given-names></name></person-group>, <etal>et al</etal>. <article-title>Imaging to evaluate suspected infective endocarditis</article-title>. <source>Cleve Clin J Med</source><year>2021</year>; <volume>88</volume>(<issue>3</issue>): <fpage>163</fpage>&#8211;<lpage>172</lpage>.<pub-id pub-id-type="pmid">33648969</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3949/ccjm.88a.19142</pub-id></mixed-citation></ref><ref id="bibr33-17539447241305587"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Habib</surname><given-names>G</given-names></name><name name-style="western"><surname>Badano</surname><given-names>L</given-names></name><name name-style="western"><surname>Tribouilloy</surname><given-names>C</given-names></name></person-group>, <etal>et al</etal>. <article-title>Recommendations for the practice of echocardiography in infective endocarditis</article-title>. <source>Eur J Echocardiogr</source><year>2010</year>; <volume>11</volume>(<issue>2</issue>): <fpage>202</fpage>&#8211;<lpage>219</lpage>.<pub-id pub-id-type="pmid">20223755</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/ejechocard/jeq004</pub-id></mixed-citation></ref><ref id="bibr34-17539447241305587"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>B</given-names></name><name name-style="western"><surname>Sanaka</surname><given-names>KO</given-names></name><name name-style="western"><surname>Haq</surname><given-names>IU</given-names></name></person-group>, <etal>et al</etal>. <article-title>Role of multimodality imaging in infective endocarditis: contemporary diagnostic and prognostic considerations</article-title>. <source>Prog Cardiovasc Dis</source><year>2023</year>; <volume>81</volume>: <fpage>78</fpage>&#8211;<lpage>88</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.pcad.2023.10.007</pub-id><pub-id pub-id-type="pmid">39492541</pub-id></mixed-citation></ref><ref id="bibr35-17539447241305587"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bai</surname><given-names>AD</given-names></name><name name-style="western"><surname>Steinberg</surname><given-names>M</given-names></name><name name-style="western"><surname>Showler</surname><given-names>A</given-names></name></person-group>, <etal>et al</etal>. <article-title>Diagnostic accuracy of transthoracic echocardiography for infective endocarditis findings using transesophageal echocardiography as the reference standard: a meta-analysis</article-title>. <source>J Am Soc Echocardiogr</source><year>2017</year>; <volume>30</volume>(<issue>7</issue>): 639&#8211;646.e8.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.echo.2017.03.007</pub-id><pub-id pub-id-type="pmid">28483353</pub-id></mixed-citation></ref><ref id="bibr36-17539447241305587"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yucel</surname><given-names>E</given-names></name><name name-style="western"><surname>Bearnot</surname><given-names>B</given-names></name><name name-style="western"><surname>Paras</surname><given-names>ML</given-names></name></person-group>, <etal>et al</etal>. <article-title>Diagnosis and Management of Infective Endocarditis in People Who Inject Drugs: JACC State-of-the-Art Review</article-title>. <source>J Am Coll Cardiol</source><year>2022</year>; <volume>79</volume>(<issue>20</issue>): <fpage>2037</fpage>&#8211;<lpage>2057</lpage>.<pub-id pub-id-type="pmid">35589166</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jacc.2022.03.349</pub-id></mixed-citation></ref><ref id="bibr37-17539447241305587"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Habets</surname><given-names>J</given-names></name><name name-style="western"><surname>Tanis</surname><given-names>W</given-names></name><name name-style="western"><surname>Reitsma</surname><given-names>JB</given-names></name></person-group>, <etal>et al</etal>. <article-title>Are novel non-invasive imaging techniques needed in patients with suspected prosthetic heart valve endocarditis? A systematic review and meta-analysis</article-title>. <source>Eur Radiol</source><year>2015</year>; <volume>25</volume>(<issue>7</issue>): <fpage>2125</fpage>&#8211;<lpage>2133</lpage>.<pub-id pub-id-type="pmid">25680715</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00330-015-3605-7</pub-id><pub-id pub-id-type="pmcid">PMC4457913</pub-id></mixed-citation></ref><ref id="bibr38-17539447241305587"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Daniel</surname><given-names>WG</given-names></name><name name-style="western"><surname>M&#252;gge</surname><given-names>A</given-names></name><name name-style="western"><surname>Grote</surname><given-names>J</given-names></name></person-group>, <etal>et al</etal>. <article-title>Comparison of transthoracic and transesophageal echocardiography for detection of abnormalities of prosthetic and bioprosthetic valves in the mitral and aortic positions</article-title>. <source>Am J Cardiol</source><year>1993</year>; <volume>71</volume>(<issue>2</issue>): <fpage>210</fpage>&#8211;<lpage>215</lpage>.<pub-id pub-id-type="pmid">8421985</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0002-9149(93)90740-4</pub-id></mixed-citation></ref><ref id="bibr39-17539447241305587"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Choussat</surname><given-names>R</given-names></name><name name-style="western"><surname>Thomas</surname><given-names>D</given-names></name><name name-style="western"><surname>Isnard</surname><given-names>R</given-names></name></person-group>, <etal>et al</etal>. <article-title>Perivalvular abscesses associated with endocarditis; clinical features and prognostic factors of overall survival in a series of 233 cases. Perivalvular Abscesses French Multicentre Study</article-title>. <source>Eur Heart J</source>.<year>1999</year>; <volume>20</volume>(<issue>3</issue>): <fpage>232</fpage>&#8211;<lpage>241</lpage>.<pub-id pub-id-type="pmid">10082156</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1053/euhj.1998.1240</pub-id></mixed-citation></ref><ref id="bibr40-17539447241305587"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Carevi&#263;</surname><given-names>V</given-names></name><name name-style="western"><surname>Mladenovi&#263;</surname><given-names>Z</given-names></name><name name-style="western"><surname>Perkovi&#263;-Avelini</surname><given-names>R</given-names></name></person-group>, <etal>et al</etal>. <article-title>Three-dimensional transesophageal echocardiography in the diagnosis and treatment of mitral prosthetic valve endocarditis&#8212;a narrative review</article-title>. <source>Medicina (Mex)</source><year>2021</year>; <volume>58</volume>(<issue>1</issue>): <fpage>23</fpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/medicina58010023</pub-id><pub-id pub-id-type="pmcid">PMC8779064</pub-id><pub-id pub-id-type="pmid">35056331</pub-id></mixed-citation></ref><ref id="bibr41-17539447241305587"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Montan&#233;</surname><given-names>B</given-names></name><name name-style="western"><surname>Chahine</surname><given-names>J</given-names></name><name name-style="western"><surname>Fiore</surname><given-names>A</given-names></name></person-group>, <etal>et al</etal>. <article-title>Diagnostic performance of contemporary transesophageal echocardiography with modern imaging for infective endocarditis</article-title>. <source>Cardiovasc Diagn Ther</source><year>2023</year>; <volume>13</volume>(<issue>1</issue>): <fpage>25</fpage>&#8211;<lpage>37</lpage>.<pub-id pub-id-type="pmid">36864958</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.21037/cdt-22-431</pub-id><pub-id pub-id-type="pmcid">PMC9971297</pub-id></mixed-citation></ref><ref id="bibr42-17539447241305587"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kaur</surname><given-names>S</given-names></name><name name-style="western"><surname>Samra</surname><given-names>GS</given-names></name><name name-style="western"><surname>Kaur</surname><given-names>M</given-names></name></person-group>, <etal>et al</etal>. <article-title>Transcatheter aortic valve replacement-associated infective endocarditis: comparison of early, intermediate, and late-onset cases</article-title>. <source>Struct Heart</source><year>2022</year>; <volume>6</volume>(<issue>1</issue>): <fpage>100005</fpage>.<pub-id pub-id-type="pmid">37273476</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.shj.2022.100005</pub-id><pub-id pub-id-type="pmcid">PMC10236854</pub-id></mixed-citation></ref><ref id="bibr43-17539447241305587"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kaur</surname><given-names>S</given-names></name><name name-style="western"><surname>Misbah Rameez</surname><given-names>R</given-names></name><name name-style="western"><surname>Jaber</surname><given-names>W</given-names></name></person-group>, <etal>et al</etal>. <article-title>Transcatheter aortic valve replacement associated infective endocarditis: a clinical update</article-title>. <source>Struct Heart</source><year>2020</year>; <volume>4</volume>(<issue>3</issue>): <fpage>152</fpage>&#8211;<lpage>158</lpage>.</mixed-citation></ref><ref id="bibr44-17539447241305587"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mylotte</surname><given-names>D</given-names></name><name name-style="western"><surname>Andalib</surname><given-names>A</given-names></name><name name-style="western"><surname>Th&#233;riault-Lauzier</surname><given-names>P</given-names></name></person-group>, <etal>et al</etal>. <article-title>Transcatheter heart valve failure: a systematic review</article-title>. <source>Eur Heart J</source><year>2015</year>; <volume>36</volume>(<issue>21</issue>): <fpage>1306</fpage>&#8211;<lpage>1327</lpage>.<pub-id pub-id-type="pmid">25265974</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/eurheartj/ehu388</pub-id></mixed-citation></ref><ref id="bibr45-17539447241305587"><label>45</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mangner</surname><given-names>N</given-names></name><name name-style="western"><surname>Woitek</surname><given-names>F</given-names></name><name name-style="western"><surname>Haussig</surname><given-names>S</given-names></name></person-group>, <etal>et al</etal>. <article-title>Incidence, predictors, and outcome of patients developing infective endocarditis following transfemoral transcatheter aortic valve replacement</article-title>. <source>J Am Coll Cardiol</source><year>2016</year>; <volume>67</volume>(<issue>24</issue>): <fpage>2907</fpage>&#8211;<lpage>2908</lpage>.<pub-id pub-id-type="pmid">27311532</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jacc.2016.03.588</pub-id></mixed-citation></ref><ref id="bibr46-17539447241305587"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aguilera</surname><given-names>J</given-names></name><name name-style="western"><surname>Hutt</surname><given-names>E</given-names></name><name name-style="western"><surname>Jaber</surname><given-names>WA.</given-names></name></person-group><article-title>Imaging of cardiac device-related infection</article-title>. <source>Front Cardiovasc Med</source><year>2021</year>; <volume>8</volume>: <fpage>729786</fpage>.<pub-id pub-id-type="pmid">34504881</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fcvm.2021.729786</pub-id><pub-id pub-id-type="pmcid">PMC8421771</pub-id></mixed-citation></ref><ref id="bibr47-17539447241305587"><label>47</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Horgan</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Mediratta</surname><given-names>A</given-names></name><name name-style="western"><surname>Gillam</surname><given-names>LD.</given-names></name></person-group><article-title>Cardiovascular imaging in infective endocarditis: a multimodality approach</article-title>. <source>Circ Cardiovasc Imaging</source><year>2020</year>; <volume>13</volume>(<issue>7</issue>): e008956.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/CIRCIMAGING.120.008956</pub-id><pub-id pub-id-type="pmid">32683888</pub-id></mixed-citation></ref><ref id="bibr48-17539447241305587"><label>48</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Saeedan</surname><given-names>MB</given-names></name><name name-style="western"><surname>Wang</surname><given-names>TKM</given-names></name><name name-style="western"><surname>Cremer</surname><given-names>P</given-names></name></person-group>, <etal>et al</etal>. <article-title>Role of cardiac CT in infective endocarditis: current evidence, opportunities, and challenges</article-title>. <source>Radiol Cardiothorac Imaging</source><year>2021</year>; <volume>3</volume>(<issue>1</issue>): e200378.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1148/ryct.2021200378</pub-id><pub-id pub-id-type="pmcid">PMC7977690</pub-id><pub-id pub-id-type="pmid">33778655</pub-id></mixed-citation></ref><ref id="bibr49-17539447241305587"><label>49</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kumar</surname><given-names>A</given-names></name><name name-style="western"><surname>Samra</surname><given-names>G</given-names></name><name name-style="western"><surname>Kaur</surname><given-names>S</given-names></name></person-group>, <etal>et al</etal>. <article-title>Mitral annular calcification related infective endocarditis: a contemporary systematic review</article-title>. <source>Curr Probl Cardiol</source><year>2023</year>; <volume>48</volume>(<issue>3</issue>): <fpage>101558</fpage>.<pub-id pub-id-type="pmid">36538998</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cpcardiol.2022.101558</pub-id></mixed-citation></ref><ref id="bibr50-17539447241305587"><label>50</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hughes</surname><given-names>D</given-names></name><name name-style="western"><surname>Linchangco</surname><given-names>R</given-names></name><name name-style="western"><surname>Reyaldeen</surname><given-names>R</given-names></name></person-group>, <etal>et al</etal>. <article-title>Expanding utility of cardiac computed tomography in infective endocarditis: a contemporary review</article-title>. <source>World J Radiol</source><year>2022</year>; <volume>14</volume>(<issue>7</issue>): <fpage>180</fpage>&#8211;<lpage>193</lpage>.<pub-id pub-id-type="pmid">36160630</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4329/wjr.v14.i7.180</pub-id><pub-id pub-id-type="pmcid">PMC9350612</pub-id></mixed-citation></ref><ref id="bibr51-17539447241305587"><label>51</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>IC</given-names></name><name name-style="western"><surname>Chang</surname><given-names>S</given-names></name><name name-style="western"><surname>Hong</surname><given-names>GR</given-names></name></person-group>, <etal>et al</etal>. <article-title>Comparison of cardiac computed tomography with transesophageal echocardiography for identifying vegetation and intracardiac complications in patients with infective endocarditis in the era of 3-dimensional images</article-title>. <source>Circ Cardiovasc Imaging</source><year>2018</year>; <volume>11</volume>(<issue>3</issue>): e006986.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/CIRCIMAGING.117.006986</pub-id><pub-id pub-id-type="pmid">29555833</pub-id></mixed-citation></ref><ref id="bibr52-17539447241305587"><label>52</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sims</surname><given-names>JR</given-names></name><name name-style="western"><surname>Anavekar</surname><given-names>NS</given-names></name><name name-style="western"><surname>Chandrasekaran</surname><given-names>K</given-names></name></person-group>, <etal>et al</etal>. <article-title>Utility of cardiac computed tomography scanning in the diagnosis and pre-operative evaluation of patients with infective endocarditis</article-title>. <source>Int J Cardiovasc Imaging</source><year>2018</year>; <volume>34</volume>(<issue>7</issue>): <fpage>1155</fpage>&#8211;<lpage>1163</lpage>.<pub-id pub-id-type="pmid">29450741</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s10554-018-1318-0</pub-id></mixed-citation></ref><ref id="bibr53-17539447241305587"><label>53</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jain</surname><given-names>V</given-names></name><name name-style="western"><surname>Wang</surname><given-names>TKM</given-names></name><name name-style="western"><surname>Bansal</surname><given-names>A</given-names></name></person-group>, <etal>et al</etal>. <article-title>Diagnostic performance of cardiac computed tomography versus transesophageal echocardiography in infective endocarditis: a contemporary comparative meta-analysis</article-title>. <source>J Cardiovasc Comput Tomogr</source><year>2021</year>; <volume>15</volume>(<issue>4</issue>): <fpage>313</fpage>&#8211;<lpage>321</lpage>.<pub-id pub-id-type="pmid">33281097</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jcct.2020.11.008</pub-id></mixed-citation></ref><ref id="bibr54-17539447241305587"><label>54</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sifaoui</surname><given-names>I</given-names></name><name name-style="western"><surname>Oliver</surname><given-names>L</given-names></name><name name-style="western"><surname>Tacher</surname><given-names>V</given-names></name></person-group>, <etal>et al</etal>. <article-title>Diagnostic performance of transesophageal echocardiography and cardiac computed tomography in infective endocarditis</article-title>. <source>J Am Soc Echocardiogr</source><year>2020</year>; <volume>33</volume>(<issue>12</issue>): <fpage>1442</fpage>&#8211;<lpage>1453</lpage>.<pub-id pub-id-type="pmid">32981789</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.echo.2020.07.017</pub-id></mixed-citation></ref><ref id="bibr55-17539447241305587"><label>55</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Koneru</surname><given-names>S</given-names></name><name name-style="western"><surname>Huang</surname><given-names>SS</given-names></name><name name-style="western"><surname>Oldan</surname><given-names>J</given-names></name></person-group>, <etal>et al</etal>. <article-title>Role of preoperative cardiac CT in the evaluation of infective endocarditis: comparison with transesophageal echocardiography and surgical findings</article-title>. <source>Cardiovasc Diagn Ther</source><year>2018</year>; <volume>8</volume>(<issue>4</issue>): <fpage>439</fpage>&#8211;<lpage>449</lpage>.<pub-id pub-id-type="pmid">30214859</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.21037/cdt.2018.07.07</pub-id><pub-id pub-id-type="pmcid">PMC6129819</pub-id></mixed-citation></ref><ref id="bibr56-17539447241305587"><label>56</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ouchi</surname><given-names>K</given-names></name><name name-style="western"><surname>Sakuma</surname><given-names>T</given-names></name><name name-style="western"><surname>Ojiri</surname><given-names>H.</given-names></name></person-group><article-title>Cardiac computed tomography as a viable alternative to echocardiography to detect vegetations and perivalvular complications in patients with infective endocarditis</article-title>. <source>Jpn J Radiol</source><year>2018</year>; <volume>36</volume>(<issue>7</issue>): <fpage>421</fpage>&#8211;<lpage>428</lpage>.<pub-id pub-id-type="pmid">29713878</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11604-018-0740-5</pub-id></mixed-citation></ref><ref id="bibr57-17539447241305587"><label>57</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Khalique</surname><given-names>OK</given-names></name><name name-style="western"><surname>Veillet-Chowdhury</surname><given-names>M</given-names></name><name name-style="western"><surname>Choi</surname><given-names>AD</given-names></name></person-group>, <etal>et al</etal>. <article-title>Cardiac computed tomography in the contemporary evaluation of infective endocarditis</article-title>. <source>J Cardiovasc Comput Tomogr</source><year>2021</year>; <volume>15</volume>(<issue>4</issue>): <fpage>304</fpage>&#8211;<lpage>312</lpage>.<pub-id pub-id-type="pmid">33612424</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jcct.2021.02.001</pub-id></mixed-citation></ref><ref id="bibr58-17539447241305587"><label>58</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dalebout</surname><given-names>EM</given-names></name><name name-style="western"><surname>Hirsch</surname><given-names>A</given-names></name><name name-style="western"><surname>Kluin</surname><given-names>J</given-names></name></person-group>, <etal>et al</etal>. <article-title>Computed tomography in infectious endocarditis</article-title>. <source>J Soc Cardiovasc Angiogr Interv</source><year>2024</year>; <volume>3</volume>(<issue>3Part B</issue>): <fpage>101292</fpage>.<pub-id pub-id-type="pmid">39131217</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jscai.2023.101292</pub-id><pub-id pub-id-type="pmcid">PMC11308100</pub-id></mixed-citation></ref><ref id="bibr59-17539447241305587"><label>59</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kamani</surname><given-names>CH</given-names></name><name name-style="western"><surname>Allenbach</surname><given-names>G</given-names></name><name name-style="western"><surname>Jreige</surname><given-names>M</given-names></name></person-group>, <etal>et al</etal>. <article-title>Diagnostic performance of 18F-FDG PET/CT in native valve endocarditis: systematic review and bivariate meta-analysis</article-title>. <source>Diagnostics (Basel)</source><year>2020</year>; <volume>10</volume>(<issue>10</issue>): <fpage>754</fpage>.<pub-id pub-id-type="pmid">32993032</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/diagnostics10100754</pub-id><pub-id pub-id-type="pmcid">PMC7601576</pub-id></mixed-citation></ref><ref id="bibr60-17539447241305587"><label>60</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>de Camargo</surname><given-names>RA</given-names></name><name name-style="western"><surname>Sommer Bitencourt</surname><given-names>M</given-names></name><name name-style="western"><surname>Meneghetti</surname><given-names>JC</given-names></name></person-group>, <etal>et al</etal>. <article-title>The role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the diagnosis of left-sided endocarditis: native vs prosthetic valves endocarditis</article-title>. <source>Clin Infect Dis</source><year>2020</year>; <volume>70</volume>(<issue>4</issue>): <fpage>583</fpage>&#8211;<lpage>594</lpage>.<pub-id pub-id-type="pmid">30949690</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/cid/ciz267</pub-id></mixed-citation></ref><ref id="bibr61-17539447241305587"><label>61</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abikhzer</surname><given-names>G</given-names></name><name name-style="western"><surname>Martineau</surname><given-names>P</given-names></name><name name-style="western"><surname>Gr&#233;goire</surname><given-names>J</given-names></name></person-group>, <etal>et al</etal>. <article-title>[18F]FDG-PET CT for the evaluation of native valve endocarditis</article-title>. <source>J Nucl Cardiol</source><year>2022</year>; <volume>29</volume>(<issue>1</issue>): <fpage>158</fpage>&#8211;<lpage>165</lpage>.<pub-id pub-id-type="pmid">32180137</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s12350-020-02092-6</pub-id></mixed-citation></ref><ref id="bibr62-17539447241305587"><label>62</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>TKM</given-names></name><name name-style="western"><surname>S&#225;nchez-Nadales</surname><given-names>A</given-names></name><name name-style="western"><surname>Igbinomwanhia</surname><given-names>E</given-names></name></person-group>, <etal>et al</etal>. <article-title>Diagnosis of infective endocarditis by subtype using 18F-fluorodeoxyglucose positron emission tomography/computed tomography: a contemporary meta-analysis</article-title>. <source>Circ Cardiovasc Imaging</source><year>2020</year>; <volume>13</volume>(<issue>6</issue>): <fpage>e010600</fpage>.<pub-id pub-id-type="pmid">32507019</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/CIRCIMAGING.120.010600</pub-id></mixed-citation></ref><ref id="bibr63-17539447241305587"><label>63</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Saby</surname><given-names>L</given-names></name><name name-style="western"><surname>Laas</surname><given-names>O</given-names></name><name name-style="western"><surname>Habib</surname><given-names>G</given-names></name></person-group>, <etal>et al</etal>. <article-title>Positron emission tomography/computed tomography for diagnosis of prosthetic valve endocarditis: increased valvular 18F-fluorodeoxyglucose uptake as a novel major criterion</article-title>. <source>J Am Coll Cardiol</source><year>2013</year>; <volume>61</volume>(<issue>23</issue>): <fpage>2374</fpage>&#8211;<lpage>2382</lpage>.<pub-id pub-id-type="pmid">23583251</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jacc.2013.01.092</pub-id></mixed-citation></ref><ref id="bibr64-17539447241305587"><label>64</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jer&#243;nimo</surname><given-names>A</given-names></name><name name-style="western"><surname>Olmos</surname><given-names>C</given-names></name><name name-style="western"><surname>Vilacosta</surname><given-names>I</given-names></name></person-group>, <etal>et al</etal>. <article-title>Accuracy of 18F-FDG PET/CT in patients with the suspicion of cardiac implantable electronic device infections</article-title>. <source>J Nucl Cardiol</source><year>2022</year>; <volume>29</volume>(<issue>2</issue>): <fpage>594</fpage>&#8211;<lpage>608</lpage>.<pub-id pub-id-type="pmid">32748277</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s12350-020-02285-z</pub-id></mixed-citation></ref><ref id="bibr65-17539447241305587"><label>65</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mahmood</surname><given-names>M</given-names></name><name name-style="western"><surname>Kendi</surname><given-names>AT</given-names></name><name name-style="western"><surname>Farid</surname><given-names>S</given-names></name></person-group>, <etal>et al</etal>. <article-title>Role of 18F-FDG PET/CT in the diagnosis of cardiovascular implantable electronic device infections: a meta-analysis</article-title>. <source>J Nucl Cardiol</source><year>2019</year>; <volume>26</volume>(<issue>3</issue>): <fpage>958</fpage>&#8211;<lpage>970</lpage>.<pub-id pub-id-type="pmid">28913626</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s12350-017-1063-0</pub-id></mixed-citation></ref><ref id="bibr66-17539447241305587"><label>66</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mikail</surname><given-names>N</given-names></name><name name-style="western"><surname>Benali</surname><given-names>K</given-names></name><name name-style="western"><surname>Dossier</surname><given-names>A</given-names></name></person-group>, <etal>et al</etal>. <article-title>Additional diagnostic value of combined angio-computed tomography and 18F-fluorodeoxyglucose positron emission tomography in infectious aortitis</article-title>. <source>JACC Cardiovasc Imaging</source><year>2018</year>; <volume>11</volume>(<issue>2 Pt 2</issue>): <fpage>361</fpage>&#8211;<lpage>364</lpage>.<pub-id pub-id-type="pmid">29055634</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jcmg.2017.07.018</pub-id></mixed-citation></ref><ref id="bibr67-17539447241305587"><label>67</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Reinders Folmer</surname><given-names>EI</given-names></name><name name-style="western"><surname>von Meijenfeldt</surname><given-names>GCI</given-names></name><name name-style="western"><surname>Te</surname><given-names>Riet</given-names></name><name name-style="western"><surname>Scholten</surname><given-names>RS</given-names></name></person-group>, <etal>et al</etal>. <article-title>A systematic review and meta-analysis of <sup>18</sup>F-fluoro-d-deoxyglucose positron emission tomography interpretation methods in vascular graft and endograft infection</article-title>. <source>J Vasc Surg</source><year>2020</year>; <volume>72</volume>(<issue>6</issue>): 2174&#8211;2185.e2.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jvs.2020.05.065</pub-id><pub-id pub-id-type="pmid">32645420</pub-id></mixed-citation></ref><ref id="bibr68-17539447241305587"><label>68</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kamiyama</surname><given-names>M</given-names></name><name name-style="western"><surname>Higaki</surname><given-names>A</given-names></name><name name-style="western"><surname>Miyabe</surname><given-names>R</given-names></name></person-group>, <etal>et al</etal>. <article-title>Right ventricular papillary muscle crossing the moderator band mimicked infective endocarditis: the utility of multimodal imaging</article-title>. <source>Oxf Med Case Rep</source><year>2024</year>; <volume>2024</volume>(<issue>4</issue>): omae026.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/omcr/omae026</pub-id><pub-id pub-id-type="pmcid">PMC11049574</pub-id><pub-id pub-id-type="pmid">38680779</pub-id></mixed-citation></ref><ref id="bibr69-17539447241305587"><label>69</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Orvin</surname><given-names>K</given-names></name><name name-style="western"><surname>Goldberg</surname><given-names>E</given-names></name><name name-style="western"><surname>Bernstine</surname><given-names>H</given-names></name></person-group>, <etal>et al</etal>. <article-title>The role of FDG-PET/CT imaging in early detection of extra-cardiac complications of infective endocarditis</article-title>. <source>Clin Microbiol Infect</source><year>2015</year>; <volume>21</volume>(<issue>1</issue>): <fpage>69</fpage>&#8211;<lpage>76</lpage>.<pub-id pub-id-type="pmid">25636930</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cmi.2014.08.012</pub-id></mixed-citation></ref><ref id="bibr70-17539447241305587"><label>70</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Duval</surname><given-names>X</given-names></name><name name-style="western"><surname>Le Moing</surname><given-names>V</given-names></name><name name-style="western"><surname>Tubiana</surname><given-names>S</given-names></name></person-group>, <etal>et al</etal>. <article-title>Impact of systematic whole-body 18F-fluorodeoxyglucose PET/CT on the management of patients suspected of infective endocarditis: the prospective multicenter TEPvENDO study</article-title>. <source>Clin Infect Dis</source><year>2021</year>; <volume>73</volume>(<issue>3</issue>): <fpage>393</fpage>&#8211;<lpage>403</lpage>.<pub-id pub-id-type="pmid">32488236</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/cid/ciaa666</pub-id></mixed-citation></ref><ref id="bibr71-17539447241305587"><label>71</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Godefroy</surname><given-names>T</given-names></name><name name-style="western"><surname>Fr&#233;con</surname><given-names>G</given-names></name><name name-style="western"><surname>Asquier-Khati</surname><given-names>A</given-names></name></person-group>, <etal>et al</etal>. <article-title>18F-FDG-based radiomics and machine learning: useful help for aortic prosthetic valve infective endocarditis diagnosis?</article-title><source>JACC Cardiovasc Imaging</source><year>2023</year>; <volume>16</volume>(<issue>7</issue>): <fpage>951</fpage>&#8211;<lpage>961</lpage>.<pub-id pub-id-type="pmid">37052569</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jcmg.2023.01.020</pub-id></mixed-citation></ref><ref id="bibr72-17539447241305587"><label>72</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rouzet</surname><given-names>F</given-names></name><name name-style="western"><surname>Chequer</surname><given-names>R</given-names></name><name name-style="western"><surname>Benali</surname><given-names>K</given-names></name></person-group>, <etal>et al</etal>. <article-title>Respective performance of 18F-FDG PET and radiolabeled leukocyte scintigraphy for the diagnosis of prosthetic valve endocarditis</article-title>. <source>J Nucl Med</source><year>2014</year>; <volume>55</volume>(<issue>12</issue>): <fpage>1980</fpage>&#8211;<lpage>1985</lpage>.<pub-id pub-id-type="pmid">25453046</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2967/jnumed.114.141895</pub-id></mixed-citation></ref><ref id="bibr73-17539447241305587"><label>73</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Swart</surname><given-names>LE</given-names></name><name name-style="western"><surname>Gomes</surname><given-names>A</given-names></name><name name-style="western"><surname>Scholtens</surname><given-names>AM</given-names></name></person-group>, <etal>et al</etal>. <article-title>Improving the diagnostic performance of 18F-fluorodeoxyglucose positron-emission tomography/computed tomography in prosthetic heart valve endocarditis</article-title>. <source>Circulation</source><year>2018</year>; <volume>138</volume>(<issue>14</issue>): <fpage>1412</fpage>&#8211;<lpage>1427</lpage>.<pub-id pub-id-type="pmid">30018167</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/CIRCULATIONAHA.118.035032</pub-id></mixed-citation></ref><ref id="bibr74-17539447241305587"><label>74</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ruiz-Zafra</surname><given-names>J</given-names></name><name name-style="western"><surname>Rodr&#237;guez-Fern&#225;ndez</surname><given-names>A</given-names></name><name name-style="western"><surname>S&#225;nchez-Palencia</surname><given-names>A</given-names></name></person-group>, <etal>et al</etal>. <article-title>Surgical adhesive may cause false positives in integrated positron emission tomography and computed tomography after lung cancer resection</article-title>. <source>Eur J Cardiothorac Surg</source><year>2013</year>; <volume>43</volume>(<issue>6</issue>): <fpage>1251</fpage>&#8211;<lpage>1253</lpage>.<pub-id pub-id-type="pmid">23242986</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/ejcts/ezs643</pub-id></mixed-citation></ref><ref id="bibr75-17539447241305587"><label>75</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lo Presti</surname><given-names>S</given-names></name><name name-style="western"><surname>Elajami</surname><given-names>TK</given-names></name><name name-style="western"><surname>Zmaili</surname><given-names>M</given-names></name></person-group>, <etal>et al</etal>. <article-title>Multimodality imaging in the diagnosis and management of prosthetic valve endocarditis: a contemporary narrative review</article-title>. <source>World J Cardiol</source><year>2021</year>; <volume>13</volume>(<issue>8</issue>): <fpage>254</fpage>&#8211;<lpage>270</lpage>.<pub-id pub-id-type="pmid">34589164</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4330/wjc.v13.i8.254</pub-id><pub-id pub-id-type="pmcid">PMC8436678</pub-id></mixed-citation></ref><ref id="bibr76-17539447241305587"><label>76</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Erba</surname><given-names>PA</given-names></name><name name-style="western"><surname>Conti</surname><given-names>U</given-names></name><name name-style="western"><surname>Lazzeri</surname><given-names>E</given-names></name></person-group>, <etal>et al</etal>. <article-title>Added value of 99mTc-HMPAO-labeled leukocyte SPECT/CT in the characterization and management of patients with infectious endocarditis</article-title>. <source>J Nucl Med</source><year>2012</year>; <volume>53</volume>(<issue>8</issue>): <fpage>1235</fpage>&#8211;<lpage>1243</lpage>.<pub-id pub-id-type="pmid">22787109</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2967/jnumed.111.099424</pub-id></mixed-citation></ref><ref id="bibr77-17539447241305587"><label>77</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kooshki</surname><given-names>N</given-names></name><name name-style="western"><surname>Grambow-Velilla</surname><given-names>J</given-names></name><name name-style="western"><surname>Mahida</surname><given-names>B</given-names></name></person-group>, <etal>et al</etal>. <article-title>Diagnostic performance of white blood cell SPECT imaging against intra-operative findings in patients with a suspicion of prosthetic valve endocarditis</article-title>. <source>J Nucl Cardiol</source><year>2022</year>; <volume>29</volume>(<issue>2</issue>): <fpage>528</fpage>&#8211;<lpage>534</lpage>.<pub-id pub-id-type="pmid">34085167</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s12350-021-02674-y</pub-id></mixed-citation></ref><ref id="bibr78-17539447241305587"><label>78</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Holcman</surname><given-names>K</given-names></name><name name-style="western"><surname>Ma&#322;ecka</surname><given-names>B</given-names></name><name name-style="western"><surname>Rubi&#347;</surname><given-names>P</given-names></name></person-group>, <etal>et al</etal>. <article-title>The role of 99mTc-HMPAO-labelled white blood cell scintigraphy in the diagnosis of cardiac device-related infective endocarditis</article-title>. <source>Eur Heart J Cardiovasc Imaging</source><year>2020</year>; <volume>21</volume>(<issue>9</issue>): <fpage>1022</fpage>&#8211;<lpage>1030</lpage>.<pub-id pub-id-type="pmid">31605137</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/ehjci/jez257</pub-id></mixed-citation></ref><ref id="bibr79-17539447241305587"><label>79</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Erba</surname><given-names>PA</given-names></name><name name-style="western"><surname>Sollini</surname><given-names>M</given-names></name><name name-style="western"><surname>Conti</surname><given-names>U</given-names></name></person-group>, <etal>et al</etal>. <article-title>Radiolabeled WBC scintigraphy in the diagnostic workup of patients with suspected device-related infections</article-title>. <source>JACC Cardiovasc Imaging</source><year>2013</year>; <volume>6</volume>(<issue>10</issue>): <fpage>1075</fpage>&#8211;<lpage>1086</lpage>.<pub-id pub-id-type="pmid">24011775</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jcmg.2013.08.001</pub-id></mixed-citation></ref><ref id="bibr80-17539447241305587"><label>80</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Litzler</surname><given-names>PY</given-names></name><name name-style="western"><surname>Manrique</surname><given-names>A</given-names></name><name name-style="western"><surname>Etienne</surname><given-names>M</given-names></name></person-group>, <etal>et al</etal>. <article-title>Leukocyte SPECT/CT for detecting infection of left-ventricular-assist devices: preliminary results</article-title>. <source>J Nucl Med</source><year>2010</year>; <volume>51</volume>(<issue>7</issue>): <fpage>1044</fpage>&#8211;<lpage>1048</lpage>.<pub-id pub-id-type="pmid">20554736</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2967/jnumed.109.070664</pub-id></mixed-citation></ref><ref id="bibr81-17539447241305587"><label>81</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>de Vaugelade</surname><given-names>C</given-names></name><name name-style="western"><surname>Mesguich</surname><given-names>C</given-names></name><name name-style="western"><surname>Nubret</surname><given-names>K</given-names></name></person-group>, <etal>et al</etal>. <article-title>Infections in patients using ventricular-assist devices: comparison of the diagnostic performance of 18F-FDG PET/CT scan and leucocyte-labeled scintigraphy</article-title>. <source>J Nucl Cardiol</source><year>2019</year>; <volume>26</volume>(<issue>1</issue>): <fpage>42</fpage>&#8211;<lpage>55</lpage>.<pub-id pub-id-type="pmid">29948892</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s12350-018-1323-7</pub-id></mixed-citation></ref><ref id="bibr82-17539447241305587"><label>82</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liberatore</surname><given-names>M</given-names></name><name name-style="western"><surname>Misuraca</surname><given-names>M</given-names></name><name name-style="western"><surname>Calandri</surname><given-names>E</given-names></name></person-group>, <etal>et al</etal>. <article-title>White blood cell scintigraphy in the diagnosis of infection of endovascular prostheses within the first month after implantation</article-title>. <source>Med Sci Monit</source><year>2006</year>; <volume>12</volume>(<issue>3</issue>): MT5-9.<pub-id pub-id-type="pmid">16501430</pub-id></mixed-citation></ref><ref id="bibr83-17539447241305587"><label>83</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Duval</surname><given-names>X</given-names></name><name name-style="western"><surname>Iung</surname><given-names>B</given-names></name><name name-style="western"><surname>Klein</surname><given-names>I</given-names></name></person-group>, <etal>et al</etal>. <article-title>Effect of early cerebral magnetic resonance imaging on clinical decisions in infective endocarditis: a prospective study</article-title>. <source>Ann Intern Med</source><year>2010</year>; <volume>152</volume>(<issue>8</issue>): <fpage>497</fpage>&#8211;<lpage>504</lpage>, W175.<pub-id pub-id-type="pmid">20404380</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.7326/0003-4819-152-8-201004200-00006</pub-id></mixed-citation></ref><ref id="bibr84-17539447241305587"><label>84</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dursun</surname><given-names>M</given-names></name><name name-style="western"><surname>Y&#305;lmaz</surname><given-names>S</given-names></name><name name-style="western"><surname>Y&#305;lmaz</surname><given-names>E</given-names></name></person-group>, <etal>et al</etal>. <article-title>The utility of cardiac MRI in diagnosis of infective endocarditis: preliminary results</article-title>. <source>Diagn Interv Radiol</source><year>2015</year>; <volume>21</volume>(<issue>1</issue>): <fpage>28</fpage>&#8211;<lpage>33</lpage>.<pub-id pub-id-type="pmid">25430531</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.5152/dir.2014.14239</pub-id><pub-id pub-id-type="pmcid">PMC4463365</pub-id></mixed-citation></ref><ref id="bibr85-17539447241305587"><label>85</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zatorska</surname><given-names>K</given-names></name><name name-style="western"><surname>Michalowska</surname><given-names>I</given-names></name><name name-style="western"><surname>Duchnowski</surname><given-names>P</given-names></name></person-group>, <etal>et al</etal>. <article-title>The usefulness of magnetic resonance imaging in the diagnosis of infectious endocarditis</article-title>. <source>J Heart Valve Dis</source><year>2015</year>; <volume>24</volume>(<issue>6</issue>): <fpage>767</fpage>&#8211;<lpage>775</lpage>.<pub-id pub-id-type="pmid">27997784</pub-id></mixed-citation></ref><ref id="bibr86-17539447241305587"><label>86</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bhuta</surname><given-names>S</given-names></name><name name-style="western"><surname>Patel</surname><given-names>NJ</given-names></name><name name-style="western"><surname>Ciricillo</surname><given-names>JA</given-names></name></person-group>, <etal>et al</etal>. <article-title>Cardiac magnetic resonance imaging for the diagnosis of infective endocarditis in the COVID-19 era</article-title>. <source>Curr Probl Cardiol</source><year>2023</year>; <volume>48</volume>(<issue>1</issue>): <fpage>101396</fpage>.<pub-id pub-id-type="pmid">36126764</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cpcardiol.2022.101396</pub-id><pub-id pub-id-type="pmcid">PMC9481470</pub-id></mixed-citation></ref><ref id="bibr87-17539447241305587"><label>87</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Urmeneta Ulloa</surname><given-names>J</given-names></name><name name-style="western"><surname>&#193;lvarez V&#225;zquez</surname><given-names>A</given-names></name><name name-style="western"><surname>Mart&#237;nez De Vega</surname><given-names>V</given-names></name></person-group>, <etal>et al</etal>. <article-title>4D flow cardiovascular magnetic resonance versus 3D transesophageal echocardiography in a mitral paravalvular leak</article-title>. <source>JACC Case Rep</source><year>2019</year>; <volume>1</volume>(<issue>3</issue>): <fpage>438</fpage>&#8211;<lpage>439</lpage>.<pub-id pub-id-type="pmid">34316850</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jaccas.2019.08.004</pub-id><pub-id pub-id-type="pmcid">PMC8289151</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>